+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Biology, Geography & Health: Chapter 35305

Chapter 35305 provides bibliographic information on scholary research in the basic and applied life, earth and health sciences.

Percival, S.; Walker, J.T., 2001:
Methods used to assess biofouling of material used in distribution and domestic water systems

Dietrich, J.; Ljunghall, S.; Sjogren, S., 2001:
Methods useful in the treatment of bone resorption diseases

Schachner, Melitta, 2003:
Methods using CNS neurite outgrowth modulators

Rosenthal, Arnon, 2003:
Methods using a novel neurotrophic factor, NT-4

Wilson, J.M.; Phaneuf, D., 2001:
Methods using cre-lox for production of recombinant adeno-associated viruses

Khalaf, Nazer K., 2000:
Methods using cross linked protein crystal formulations as catalysts in organic solvents

Aoyagi, K.; Livak, K.J., 1999:
Methods using exogenous, internal controls and analogue blocks during nucleic acid amplification

Larocca, D.; Kassner, P.; Baird, A., 2004:
Methods using genetic package display for detecting and identifying protein protein interactions that facilitate internalization and transgene expression and cells or tissues competent for the same and methods for evolving gene delivery vectors

Akerstrom, G.; Juhlin, C.; Rask, L.; Hjalm, G.; Morse, C.C.; Murray, E.M.; Crumley, G.R., 2001:
Methods using human calcium sensor protein, fragments thereof and DNA encoding same

Cohn, J.N.; Carson, P., 2004:
Methods using hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate

Paoletti, E.; Panicali, D., 1999:
Methods using modified vaccinia virus

Johnson, E.M.J.; Milbrandt, J.D.; Kotzbauer, P.T.; Lampe, P.A., 2003:
Methods using persephin and related growth factors

Love, S.M.; Hung, D.; He, X., 2002:
Methods using pressure to obtain fluids and cellular material from breast ducts

Qiu, X.; Osborne, N.F.ederick; Richardson, C.M.ry; Janson, C.A., 2001:
Methods using the staphylococcus aureus glycyl tRNA synthetase crystalline structure

Dodd, M.T.; Trinh, T.; Bartolo, R.G.; Lucas, J.M.; Buckner, R.Y.; Kajs, T.M., 1999:
Methods using uncomplexed cyclodextrin solutions for controlling environmental odors

Lukin, Kirill A., 2002:
Methods utilizing aryl thioimines in synthesis of erythromycin derivatives

Riley, P.A.; Babcock, T., 1999:
Methods utilizing compositions containing sacred lotus to treat aging skin

Cullen, Bryan R., 2001:
Methods utilizing mutant rev genes encoding transdominant repressors of HIV replication

Cerami, A.; Cerami, C.; Ulrich, P., 2000:
Methods, agents and devices for removing nucleophilic toxins from tobacco and tobacco smoke

Matthews, W.A.; Banks, J.N.; Chaudhry, M.Q., 2000:
Methods, agents and kits for detection of organophosphorus compounds

Haaland, P.D.; Nadeau, J.G.; Nycz, C.M.; Dean, C.H.; Spargo, C.A., 2000:
Methods, apparatus and computer program products for determining quantities of nucleic acid sequences in samples using standard curves and amplification ratio estimates

Mittelstein, M.; Sorensen, J.T.; Mirhashemi, S.; Gerg, J.B.; Muri, J.I.; Etherington, R.F.; Ripley, J.A., 2003:
Methods, apparatus and system for removal of lenses from mammalian eyes

Perlich, T.; Goodsill, C., 2004:
Methods, apparatus, and compositions for controlling organisms in ballast water

Oldham, M.F.oyd; Honebein, P.C.rlton, 2001:
Methods, apparatus, articles of manufacture, and user interfaces for performing automated biological assay preparation and macromolecule purification

Muller, Timo, 2002:
Methods, apparatuses and imaging mode for tomographic imaging

Miwa, H.; Kino, M., 2003:
Methods, apparatuses and medicaments for treating body fluid related diseases

Moberg, S.B.; Causey, J.D.I.i; Bare, R.O.; Scherer, A.J.; Sargent, B.J., 2002:
Methods, apparatuses, and uses for infusion pump fluid pressure and force detection

Wysocki, Charles J., 2002 :
Methods, approaches, and caveats for evaluating human olfaction and chemesthesis

O'keefe, R.J.mes; Rosier, R.N.than, 2000:
Methods, articles and compositions for the pharmacologic inhibition of bone resorption with phosphodiesterase inhibitors

Richter, A.M.; Levy, J.G.; Hariton, C.A.A.; Huber, G.; Stewart, W.C.; Fsadni, M.G.; Obochi, M.O.K., 2004:
Methods, compositions and articles for reducing or preventing the effects of inflammation

Finkelstein, S.P.; Snyder, E.Y., 2004:
Methods, compositions and kits for promoting recovery from damage to the central nervous system

Belloni, Paula N., 2004:
Methods, compositions and modes of delivery for the treatment of emphysema using 13-cis-retinoic acid

Cawthon, Garret D., 2003:
Methods, compositions and systems for the prevention and treatment of diaper rash

Morse, D.E.; Stucky, G.D.; Deming, T.D.; Cha, J.; Shimizu, K.; Zhou, Y., 2003:
Methods, compositions, and biomimetic catalysts for in vitro synthesis of silica, polysilsequioxane, polysiloxane, and polymetallo-oxanes

Upasani, R.B.; Xia, H.; Hogenkamp, D., 2000:
Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series

Zhang, J.; Li, J.H., 2002:
Methods, compounds and compositions for treating gout

Dubrow, R.S.; Bloxsom, C.; Chow, C.Y.H.; Parce, J.W.llace, 2002:
Methods, devices and systems for characterizing proteins

Chan, S.D.H.; Chien,; Chow, A.W.; Wang, B.N., 2003:
Methods, devices, and systems for monitoring time dependent reactions

Stefano, K.; Coull, J.M.; Stender, H.; Hyldig Nielsen, J.J.; Peterson, K.H., 2001:
Methods, kits and compositions for detecting and quantitating target sequences

Johansen, J.T.; Hyldig Nielsen, J.J.; Fiandaca, M.J.; Coull, J.M., 2002:
Methods, kits and compositions for the identification of nucleic acids electrostatically bound to matrices

Kacena, Katherine, 2002:
Methods, kits and compositions of matter useful for determining Chlamydia pneumoniae

Coull, J.M.; Gildea, B.D.; Hyldig Nielsen, J.J., 2002:
Methods, kits and compositions pertaining to PNA molecular beacons

Gildea, B.D.; Coull, J.M.; Hyldig Nielsen, J.J.; Fiandaca, M.J., 2002:
Methods, kits and compositions pertaining to linear beacons

Cantor, T.L.; Gao, P., 2004:
Methods, kits, and antibodies for detecting parathyroid hormone

Even Tov, I.; Naveh, A.; Kuperman, I., 2001:
Methods, kits, electrodes and compositions for assessing the level of an analyte of interest in fluid samples

Su, M., 1999:
Methods, nucleotide sequences and host cells for assaying exogenous and endogenous protease activity

Rapaport, Eliezer, 2004:
Methods, pharmaceutical and therapeutic compostions for administering adenosine

Fox,; Jones, D.M.ckay, 1999:
Methods, primers, and kits for detection and speciation of Campylobacter

Schork, N.J.; Essioux, L.; Cohen Akenine, A.; Blumenfeld, M.; Cohen, D., 2001:
Methods, software and apparati for identifying genomic regions harboring a gene associated with a detectable trait

Turcott, R.; O'hara, C., 2004:
Methods, systems and devices for optimizing cardiac pacing parameters

Turcott, Robert, 2003:
Methods, systems and devices for optimizing cardiac pacing parameters using evolutionary algorithms

French, R.; Andreas, B.H.; Gifford, H.S.I.i, 2004:
Methods, systems and devices relating to implantable fluid pumps

Greene, M.I.; Eberwine, J.; Kacharmina, J.E.tee; Zhang, H.T.o, 2004:
Methods, systems and kits for immuno-detection of epitopes expressed on molecules

Riviere, J.E.; Martin Jimenez, T.; Baynes, R.E.; Craigmill, A.L., 2000:
Methods, systems and products for determining drug withdrawal intervals

Scarantino, C.W.; Nagle, H.T.oy; Hall, L.C.; Mueller, J.S.; Kim, C.S.o, 2002:
Methods, systems, and associated implantable devices for dynamic monitoring of physiological and biological properties of tumors

Otvos, James D., 2003:
Methods, systems, and computer program products for analyzing and presenting NMR lipoprotein-based risk assessment results

Trahey, G.E.; Nightingale, K.R.; Nightingale, R.W.; Mcaleavey, S., 2004:
Methods, systems, and computer program products for imaging using virtual extended shear wave sources

Orth, M.J.; Yang, M.C., 2001:
Methods, systems, and kits for implanting articles

Newman, C.M.H.; Brisken, A.F., 2002:
Methods, systems, and kits for intravascular nucleic acid delivery

Perkins, R.A.; Soltesz, P.P.; Kotmel, R., 2001:
Methods, systems, and kits for lung volume reduction

Mathur, R.; Lawrence, N., 2001:
Methods, uses and compositions of fluid petrolatum

Wernerman, J.; Rooyackers, O., 2000:
Methods, who cares?

Napolitano, C.A.; Castro, M.I., 2002:
Methohexital An Intravenous Agent with Minimal Effects upon Ventricular Repolarization during the Induction of General Anesthesia

Rossi, M.A.; Hoeppner, T.J.; Kanner, A.M.; Smith, M.C., 2002:
Methohexital suppression augments scalp dipole-source localization modeling of complex interictal epileptiform discharges

Kodrik,D.; Alquicer,G.; Socha,R., 2010:
Methoprene modifies adipokinetic hormone characteristics in the firebug Pyrrhocoris apterus

O'dell, J.; Leff, R.; Paulsen, G.; Haire, C.; Mallek, J.; Eckhoff, P.J.mes; Fernandez, A.; Blakely, K.; Wees, S.; Hadley, S.; Felt, J.; Palmer, W.; Waytz, P.; Churchill, M.; Klassen, L., 1999:
Methotrexate -hydroxychloroquine -sulfasalazine versus M-H or M-S for rheumatoid arthritis Results of a double-blind study

Rots, M.G.; Pieters, R.; Kaspers, G.J.L.; Noordhuis, P.; Van Zantwijk, C.H.; Creutzig, U.; Peters, G.J.; Veerman, A.J.P.; Jansen, G., 1999:
Methotrexate An overlooked drug in the treatment of acute myeloid leukemia ?

Wallace, C.A., 2000:
Methotrexate: more questions than answers

Giannini, E.H., 2002:
Methotrexate: vital new information about a middle aged drug

Carstensen, H., 2001:
Methotrexate and 6-mercaptopurine in the treatment of Langerhans Cell Histiocytosis

Fiehn, C.; Neumann, E.; Wunder, A.; Krienke, S.; Gay, S.; Mueller Lander, U., 2004:
Methotrexate and albumin coupled with MTX suppress synovial fibroblast invasion and cartilage degradation in vivo

Uziel, Y.; Feldman, B.M.; Krafchik, B.R.; Yeung, R.; Laxer, R.M., 1999:
Methotrexate and corticosteroids in pediatric localized scleroderma A promising response

Van Den Brande, J.M.; Braat, H.; Bauer, C.A.; Peppelenbosch, M.P.; Van Deventer, S.J.; Hommes, D.W., 2003:
Methotrexate and infliximab act synergistic by inducing enhanced apoptosis in activated human lymphocytes

Kremer, J.M., 1999:
Methotrexate and leflunomide: biochemical basis for combination therapy in the treatment of rheumatoid arthritis

Rohde, K.; Volk, E.; Rhee, M.; Mcguire, J.; Schneider, E., 1999:
Methotrexate and mitoxantrone cross-resistance in selected drug-resistant MCF7 breast cancer cells

Fries, J.F.; Schettler, J.; Ramey, D., 1999 :
Methotrexate and mortality in rheumatoid arthritis Simpsons paradox and other methodological problems

Cadrobbi, R.; Baldan, N.; Vinanzi, C.; Taglioni, A.; Castagnaro, M.; D.B.nedictis, G.; Carraro, P.; Cancellotti, F.; Cozzi, E.; Ancona, E., 2001:
Methotrexate as induction agent in life-supporting hDAF pig-to-primate renal xenotransplantation

Rosh, J.R.; Youssef, N.N.; Schuckalo, S.; Punati, J.; Fehling, B.; Mones, R.L., 2003:
Methotrexate as rescue therapy in pediatric crohns disease

Reuben, Adrian, 2003:
Methotrexate controversies

Matsuoka, H.; Suzuki, H.; Kato, N.; Tsuji, K.; Kuroki, T.; Maruyama, N.; Nakagomi, K., 2003:
Methotrexate derivatives

Xue, L.Y.; Butler, N.J.; Kirichian, A.M.; Adelstein, S.J.; Kassis, A.I., 2002:
Methotrexate enhances potential of 5-125I-iodo-2-deoxyuridine in the treatment of neoplastic meningitis

Li, Yu; Kwon, Glen S., 2000:
Methotrexate esters of poly -block-poly Part I Effects of the level of methotrexate conjugation on the stability of micelles and on drug release

Jeron, A.; Fredersdorf, S.; Straub, R.; Riegger, G.A.J.; Muders, F., 2000:
Methotrexate fails to suppress cardiac cytokine induction in pressure overload hypertrophy in rats

Malcangi, G.; Cappelli, M.; Palmieri, C.; Brandozzi, G.; Danieli, M.G., 2001:
Methotrexate for the treatment of bullous systemic lupus erythematosus

Cartwright, V.W.; Wolf, F.M., 2003:
Methotrexate in JCA Defining its efficacy A systematic review

Ravelli, A.; Martini, A., 2000:
Methotrexate in juvenile idiopathic arthritis: answers and questions

Heufelder, A.E.; Schworm, H.D.; Heufelder, G., 2000:
Methotrexate in the treatment of refractory Graves ophthalmopathy

Moe, P.J.; Holen, A.; Nygaard, R.; Glomstein, A.; Madsen, B.; Hellebostad, M.; Stokland, T.; Wefring, K.W.; Steen Johnsen, J.; Nielsen, B.; Hapnes, C.; Borsting, S., 2002:
Methotrexate infusions as CNS prophylaxis in children with acute lymphocytic leukaemia The Norwegian experience

Ohya, N.; Yamada, H.; Hama, N.; Kikukawa, T.; Ichikawa, Y., 1999:
Methotrexate inhibits IL-6 and matrix metalloproteinase-2 production by mixed synoviocytes from patients with rheumatoid arthritis

Gerards, A.H.; D.G.oot, E.R.; Dijkmans, B.A.C.; Aarden, L.A., 1999:
Methotrexate inhibits TNFalpha and IFNgamma in whole blood cultures of patients with rheumatoid arthritis

Gudjonsson, J.E.; Sigmundsdottir, H.; Ludviksson, B.R.; Valdimarsson, H., 2001:
Methotrexate inhibits expression of CLA by T cells in vitro

Curreli, F.; Cerimele, F.; Cesarman, E.; Friedman Kien, A.E.; Flore, O., 2001:
Methotrexate inhibits the switch of Kaposi S sarcoma-associated-herpesvirus from latency to lytic replication by transcriptional down-regulation of ORF50/Rta

Huang, F.S.; Ye, Y.; Marquart, F.L.; Chung, D.H.; Evers, B.M.rk, 2003:
Methotrexate injury induces increased expression of cyclooxygenase 2 and prostaglandins in intestinal epithelial cells

Drosos, A., 2003:
Methotrexate intolerance in elderly patients with rheumatoid arthritis: what are the alternatives?

Teranishi, K.; Treter, S.; Awwad, M.; Cooper, D., 2001:
Methotrexate is an ineffective immunosuppressive agent in baboons

Crews, K.R.; Evans, W.E.; Pui, C.H.n; Panetta, J.C.rl; Relling, M.V., 2001:
Methotrexate pharmacokinetics following hypouricemic treatment with allopurinol vs urate oxidase in children with acute lymphoblastic leukemia

Wang, D.; Dressman, L.A.; Rose, B.; Moreng, G.; Rowe, E.S.; Rowe, V., 2001:
Methotrexate pulse therapy on MSFC and cellular immunology markers in patients with relapsing progressive multiple sclerosis

Prodanovich, S.; Prodanowich, S.; Ma, F.; Taylor, J.Richard.; Pezon, C.; Fasihi, T.; Kirsner, R.S., 2005:
Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis

Boettcher, H.; Costard-Jäckle, A.; Möller, F.; Hirt, S.W.; Cremer, J., 2002:
Methotrexate rescue therapy in lung transplantation

Volk, E.L.; Farley, K.M.; Schneider, E., 2002:
Methotrexate resistance of cells overexpressing the breast cancer resistance protein is determined by the amino acid at position 482

Parcharidou, A.A.; Micraki Christou, V.; Papadakis, V.; Karigianna, A.; Haidas, S., 2000:
Methotrexate serum levels following intrathecal MTX infusion in children with ALL during maintenance

Majumdar, S.; Aggarwal, B.B., 2001:
Methotrexate suppresses nuclear factor-kB activation through inhibition of IKBA phosphorylation and degradation

Hommes, D.W.; Van Den Brande, J.; Stokkers, P.; Deley, M.; Van Deventer, S., 2003:
Methotrexate therapy for crohns disease long term efficacy and safety

Corrigan, C.J.; Shakur, B.H.; Ind, P.W.; Shiner, R.J., 2000:
Methotrexate therapy of steroid-dependent asthma is associated with reduced serum total IgE concentrations

Laurindo, I.M.M.; Novaes, G.S.; D.M.llo, S.B.V.; Carmo, A.O.; Monteiro, H.P., 2001:
Methotrexate therapy reduces nitric oxide levels in synovial fluid of rheumatoid arthritis patients

Curran, S.; Winchester, R.; Costello, P.; Peterson, K.; Bresnihan, B.; Fitzgerald, O., 1999:
Methotrexate therapy reduces polyclonal T-cell infiltration in the psoriatic arthritis synovium, revealing expanded CD4 and CD8 T-cell clones

Velez, F.F.; Mantilla, R.D.; Correa, P.A.; Anaya, J.M.nuel, 1999:
Methotrexate treatment in early rheumatoid arthritis Clinical efficacy in spite of radiographic progression

Igbokwe, U.O.; Gould, D.J.; Burt, A.D.; Mathew, J., 2003:
Methotrexate, psoriasis and alpha1-antitrypsin deficiency A cocktail for liver fibrosis?

Wolff, D.; Frei, E.; Steiner, B.; Sievert, K.; Terpe, H.; Schrenk, H.H.rmann; Hartung, G.; Freund, M., 2003:
Methotrexate-albumin and aminopterin-albumin are effective in prophylaxis of experimental acute GVHD

Mickisch, G.H.; Wildhagen, M.; Mulder, E.; Schmidt, C.; V.G.ast, A., 2001:
Methotrexate-human serum albumin as second line treatment for metastatic renal cell cancer refractory to immunotherapy

Frei, E.; Weigand, M.; Schrenk, H.H.; Wiessler, M.; Kiprianova, J.; Fritzsche, T.; Wolf, M.; Neuwirth, F.; Breuer, A.; Sinn, H., 2001:
Methotrexate-human serum albumin; a new therapeutic principle in oncology

Schwanzel Fukuda, M., 2000:
Methotrexate-induced aberrant formation of the migration route of LHRH neurons may result from an effect on vasculogenesis in the olfactory placode and nasal mesenchyme of embryonic mice

Mahrle, G.; Barry, R.; Sauer, H.; Wartenberg, M.; Niland, S.; Hescheler, J., 2001:
Methotrexate-induced apoptosis in human keratinocytes is mediated by the CD35-receptor

Batres, L.Arturo.; Gabriel, C.A.; Tsou, V.Marc., 2003:
Methotrexate-induced esophagitis in a child with Crohn disease

Borcea, A.; Greaves, M.W., 2000:
Methotrexate-induced exacerbation of urticarial vasculitis: an unusual adverse reaction

Jaksic, W.; Veljkovic, D.; Pozza, C.; Lewis, I., 2004:
Methotrexate-induced leukoencephalopathy reversed by aminophylline and high-dose folinic acid

Camidge, D.R., 2001:
Methotrexate-induced radiation recall

Yoruk, A.; Cizmecioglu, F.; Yukselgungor, H.; Timur, C.; Baydilli, H.; Ozcay, S., 2002:
Methotrexate-induced systemic vasculitis

Gerdes, P.; Gayer, H.; Heinemann, U.; Kruger, B.W.eland; Mauler Machnik, A.; Hanssler, G.; Stenzel, K., 2001:

Gayer, H.; Gerdes, P.; Heinemann, U.; Kruger, B.W.eland; Stenzel, K., 2002:

Maurer, F.; Gayer, H.; Gerdes, P.; Heinemann, U.; Kruger, B.W.eland; Markert, R.; Stenzel, K.; Hanssler, G.; Mauler Machnik, A., 2002:
Methoximinophenylacetic acid amides

Imperante, J.; O'lenick, A.J.Jr, 2002:
Methoxy capped alkoxylated glycerin compounds

Dong, Yuancai; Feng, S.S.en, 2004:
Methoxy poly -poly nanoparticles for controlled delivery of anticancer drugs

Khuu, H.M.; Marques, M.B.; Huang, Z.; Annunziata, D.; Huang, S.T., 1999:
Methoxy- and crosslinked polyethylene glycol binding to red cells is stable and does not affect cell membrane function

Gerson, S.L.; Liu, L., 2003:
Methoxyamine combinations in the treatment of cancer

Liu, L.; Donze, J.R.; Gerson, S.L., 2002:
Methoxyamine enhances antitumor efficacy of BCNU in colon tumor xenografts

Liu, L.; Nakatsuru, Y.; Gerson, S.L., 2000:
Methoxyamine mediated inhibition of base excision repair significantly enhances temozolomide antitumor effect in mismatch repair proficient and deficient colon cancer xenografts

Taverna, P.; Liu, L.; Hwang,; Kinsella, T.J.; Gerson, S.L., 2000:
Methoxyamine potentiates DNA Single Strand and Double Strand Breaks induced by temozolomide in colon cancer cells

Gerson, S.L.; Liu, L., 2002:
Methoxyamine potentiation of temozolomide anti-cancer activity

Youngblood, R.C.; Dickerson, T.W.; Willard, S.T.; Ryan, P.L., 2004:
Methoxychlor exposure does not alter vascular endothelial growth factor receptor 2-mediated gene expression in a novel transgenic mouse wound model

Ottinger, M.A.n; Wu, J.M.; Hazelton, J.L.; Abdelnabi, M.A.; Sitzmann, B., 2003 :
Methoxychlor impacts reproductive maturation in an avian model, the Japanese quail

Borgeest, C.; Symonds, D.; Flaws, J.A., 2002:
Methoxychlor may alter the levels of Bcl-2 protein in the mouse ovary

Borgeest, C.; Tomic, D.; Greenfeld, C.; Babus, J.K.; Symonds, D.; Flaws, J.A., 2003:
Methoxychlor may regulate estrogen receptor levels in the mouse ovary

Miller, K.P.; Borgeest, C.; Flaws, J.A., 2003:
Methoxychlor metabolism may induce antral follicle specific toxicity in the mouse

Deflorio, V.; Corey, J.M.chael; Vargas, A., 1999:
Methoxycinnamyloxy salycilate and preparation thereof

Dean, N.M.; Martin, P.; Altmann, K.H.inz, 1999:
Methoxyethoxy oligonucleotides for modulation of protein kinase C expression

Chen, W.; Bennett, C.F.; Condon, T.P.; Stecker, K.; Tian, L.; Kahan, B.D.; Stepkowski, S.M., 2001:
Methoxyethyl modification of phosphorothioate ICAM-1 antisense oligonucleotides improves prevention of ischemic/reperfusion injury

Yu, M.; Klaess, T.; Kozikowski, A.P.; Brownell, A., 2003:
Methoxymethyl - MTEP and methoxy - PEPy, potent and selective PET radioligands for metabotropic glutamate subtype 5 receptors

Anderson, J.J.; Rao, S.P.; Rowe, B.; Giracello, D.R.; Holtz, G.; Chapman, D.F.; Tehrani, L.; Bradbury, M.J.; Cosford, N.D.P.; Varney, M.A., 2002:
Methoxymethyl-3- ethynylpyridine binding to metabotropic glutamate receptor subtype 5 in rodent brain In vitro and in vivo characterization

Cosford, N.D.P.; Roppe, J.; Tehrani, L.; Schweiger, E.J.; Seiders, T.J.n; Chaudary, A.; Rao, S.; Varney, M.A., 2003:
Methoxymethyl-MTEP and -methoxy-PEPy Potent and selective radioligands for the metabotropic glutamate subtype 5 receptor

Heinemann, U.; Gayer, H.; Gerdes, P.; Vaupel, M.; Mauler Machnik, A.; Hanssler, G.; Stenzel, K.; Kugler, M.; Jaetsch, T.; Wachtler, P., 2002:
Methoxymino-phenylacetamide derivatives and their utilization as pesticides

Polouchine, Nikolai N., 1999:
Methoxyoxalamido and succinimido precursors for nucleophilic addition to nucleosides, nucleotides and oligonucleotides

Murad, K.L.; Scott, M.D., 1999:
Methoxypoly derivatization of red blood cells Effects on antibody-mediated aggregation, sedimentation rate, and rouleaux formation

Newcombe, D.A.; Paszczynski, A.; Gajewska, W.; Kroeger, M.; Crawford, R., 2001:
Methoxyquinone production and the mechanism of 2,4,6-trinitrotoluene degradation by Gloeophyllum species

Eriksson, B.I.; Arfwidsson, A.C.; Frison, L.; Eriksson, U.; Bylock, A.; Kalebo, P.; Fager, G.; Gustafsson, D., 2000:
Methro I Dose ranging study of H376/95, a novel, oral, direct thrombin inhibitor, and its subcutaneous formulation, melagatran, for prophylaxis of venous thromboembolism after total hip and total knee replacement

Eriksson, B.I.; Lindbratt, S.; Kalebo, P.; Bylock, A.; Frison, L.; Welin, L.; Dahl, O.; Gustafsson, D., 2000:
Methro II Dose-response study of the novel oral, direct thrombin inhibitor, H 376/95 and its subcutaneous formulation melagatran, compared with dalteparin as thromboembolic prophylaxis after total hip or total knee replacement

Austad, S.N., 2010:
Methusaleh's Zoo: how nature provides us with clues for extending human health span

Lin, Y.J.un; Benzer, S., 2001:
Methuselah gene, compositions and methods of use

Casimir, J.R.chard; Guichard, G.; Briand, J.P.ul, 2002:
Methyl 2- carbonylbenzoate

Ravert, H.T.; Mathews, W.B.; Musachio, J.L.; Scheffel, U.; Finley, P.; Dannals, R.F., 1999:
Methyl 4- acetyl-3-

Lowe, N.J.; Yamouchi, P.; Lask, G.; Pariser, D.; Lucky, A.; Stewart, D.; Jarratt, M., 2001:
Methyl 5-aminoleavulinate photodynamic therapy for multiple actinic keratoses

Yamauchi, P.S.; Lowe, N.J.; Lask, G.P.; Patnaik, R.; Moore, D.; Foley, P., 2002:
Methyl aminolevulinate and photodynamic therapy in the treatment of actinic keratosis

Thaper, R.K.mar; Kumar, S.M.dhava Dileep; Kumar, Y., 2003:
Methyl analogs of simvastatin as novel HMG-CoA reductase inhibitors

Zeise, M.L.; Jofre, D.; Barraza, X., 1999:
Methyl bromide Is the glutathione transferase pathway the key to its neurotoxicity?

Norton, Del, 2002:
Methyl bromide Touching all our lives

Gilreath, J.P.; Noling, J.W.; Santos, B.M., 2004:
Methyl bromide alternatives for bell pepper and cucumber rotations

Gilreath, J.P.; Noling, J.W.; Santos, B.M., 2003:
Methyl bromide alternatives for pepper and cucumber rotations

Sanders, D.C.; Monks, D.W.; Ferguson, L.M.; Louws, F.J.; Creel, K., 2002:
Methyl bromide alternatives for several vegetable production systems

Schneider, S.M.; Trout, T.J.; Gerik, J.S.; Ajwa, H., 2003:
Methyl bromide alternatives for vine, tree, and berry field nurseries

Goodwin, K.D.; Stephens, F.C.; Tokarczyk, R.; Saltzman, E.S.; Taylor, B.F., 2001:
Methyl bromide degradation by a bacterial culture grown aerobically on toluene

Wakabayashi, K.; Hoson, T.; Huber, D.J., 2003:
Methyl de-esterification as a major factor regulating the extent of pectin depolymerization during fruit ripening A comparison of the action of avocado and tomato polygalacturonases

Bossenmeyer-Pourié, C.; Blaise, Sébastien.; Pourié, Gégory.; Tomasetto, C.; Audonnet, S.; Ortiou, S.; Koziel, V.; Rio, M-Christine.; Daval, J-Luc.; Guéant, J-Louis.; Beck, B., 2010:
Methyl donor deficiency affects fetal programming of gastric ghrelin cell organization and function in the rat

Saloua, F.; Saber, C.; Hedi, Z., 2010:
Methyl ester of [Maclura pomifera (Rafin.) Schneider] seed oil: biodiesel production and characterization

Satyanarayana,M.; Muraleedharan,C., 2010:
Methyl ester production from rubber seed oil using two-step pretreatment process

Miles, D.H.ward; Petrovna,; Naser, S.; Yurjevich, S.S.rgey; Goun, E.A.; Michailovich, S.V.adimir, 2004:
Methyl esters of substituted 4-oxo-2-butenoic acid for treatment of tuberculosis

Vargas, R.I.; Stark, J.D.; Kido, M.H.; Ketter, H.M.; Whitehand, L.C., 2000:
Methyl eugenol and cue-lure traps for suppression of male oriental fruit flies and melon flies in Hawaii Effects of lure mixtures and weathering

Amortegui, A.J.; Trucco, G.; Wiesenfeld, H.; Hindi, A.; Bogda, K.; Pomponio, A.; Sweet, R.L., 2000:
Methyl green pyronin stain and important aid in the diagnosis of chronic endometritis A retrospective study

Blaha, M.D.; Kohl, J.C.; Dubose, D.A., 2001:
Methyl green stain as a visual qualitative tool of DNase I-associated apoptotic events in CEES-exposed epiderm

Cohen, B.D., 2002:
Methyl group deficiency States

Chatfield, David, 2001:
Methyl groups as probes of structure and dynamics in peptides and proteins

Clasquin, Michelle F., 2003:
Methyl halide production in Vermont soils

Risch, K.; Strebel, H.P.; Joshi, R.K.; Lutz, J.; Brock, J.; Asadullah, K.; Volk, H.; Lehmann, M., 2001:
Methyl hydrogen fumarate inhibits acute and chronic rejection in rat kidney transplantation models

Poirier, L.A.; Wise, C.K.; Delongchamp, R.R.; Buffington, C.K.; Cowans, G.S.M.; Feuers, R., 2003:
Methyl intermediates in the blood of gastric bypass patients

Eayre, C.G.; Sims, J.J.; Ohr, H.D., 1999:
Methyl iodide soil fumigation for the control of peach replant disorder

Rubin, A.L.; Thongsinthusak, T.; Pfeifer, K.F., 2003:
Methyl isothiocyanate Risk to humans following agricultural applications of metam sodium

Burns, J.K.; Hartmond, U.; Yuan, R.; Kender, W.J., 1999:
Methyl jasmonate causes ethylene production and abscission in citrus

Comparot, S.M.; Pidgeon, C.M.; Reid, D.M., 2000:
Methyl jasmonate elicits a differential response of superoxide dismutase activity in light- and dark-grown seedlings of Arabidopsis thaliana

Abram, V.; Donko, M.; Bernjak, D., 2000:
Methyl jasmonate induced response in the leaves of Lycopersicum esculentum cv Arletta

Han, O.; Kim, E.; Choi, E., 2001:
Methyl jasmonate induces biphasic accumulation of lipoxygenase mRNA in maize seedlings

Ding, C.K.i; Wang, C.Y.; Gross, K.C., 2001:
Methyl jasmonate induces stress-related gene expression and increases chilling tolerance in tomato fruit

Kozlowski, G.; Buchala, A.; Metraux, J.P., 1999:
Methyl jasmonate protects Norway spruce Karst seedlings against Pythium ultimum Trow

Cho, S.; Ku, M.S.B.; Dai, Z.; Hooker, B.S., 1999:
Methyl jasmonate-induced changes in protein profile in maize leaves

Fedina, I.S.; Dimova, L.M., 2000:
Methyl jasmonate-induced polypeptides in Pisum sativum roots soluble proteins

Saniewski, M.; Ueda, J.; Miyamoto, K., 1999:
Methyl jasmonate-induced secondary abscission in shoot of Bryophyllum calycinum Salisb

Calter, M.; Liao, W., 2001:
Methyl ketene as a useful synthon for the efficient asymmetric total syntheses of siphonarienes

Qian, J.; Skyllberg, U.; Frech, W.; Bleam, W.F.; Bloom, P.R.; Petit, P.E., 2003:
Methyl mercury and reduced sulfur group interactions in stream and soil organic matter

Dicicco Bloom, E.M.; Reuhl, K.R.; Cheng, Y.; Petrov, A.; Caldiera, N., 2003:
Methyl mercury exposure of newborn rats differentially inhibits neurogenesis in hippocampus and cerebellum

Sidhu, J.S.; Hong, S.; Erickson, A.; Baker, A.; Robinson, J.; Vliet, P.; Faustman, E.M., 2003:
Methyl mercury induces differential ubiquitin-conjugated protein levels in p53 variant mouse embryonal fibroblasts

Holmes, J.; Lean, D., 2000:
Methyl mercury production in agriculturally impacted wetlands and bogs

Blecher, D.; Suter, W.; Martus, H.J., 2001:
Methyl methane sulfonate mutagenicity in pUR288 transgenic mice

Glaab, W.E.; Tindall, K.R.; Skopek, T.R., 1999:
Methyl methanesulfonate-induced mutational specificity in mismatch repair-deficient human cancer cell lines

Dementyeva, N.P.; Korman, D.B., 2001:
Methyl nitrosourea 30 years of study and application for treatment of cancer patients

Hutchins, J.B.air; Averett, N.; Bernanke, J.; Kramer, R.E.; Baker, R.C., 2002:
Methyl parathion intoxication alters the neurochemistry of the septohippocampal pathway

Rockhold, R.W.; Ho, I.K.; Zhu, H., 2001:
Methyl parathion masks withdrawal from physical dependence on morphine

Hutchins, J.B.air; Baker, R.C.; Kramer, R.E., 2001:
Methyl parathion treatment alters the neurochemistry of the developing ferret visual system

Rowsey, P.J.; Gordon, C.J., 2000 :
Methyl scopolamin An antipyretic for stress-induced and chlorpyrifos -induced fever but not lipopolysaccharide-induced fever in the rat

Cunningham, R.L.nn; Taylor, J.A.; Welshons, W.V.; Heesch, C.M., 2003:
Methyl tert butyl ether extraction method for rodent estradiol radioimmunoassay

Attilio, M.J.; Redmond, B.W.; Baker, K.H.; Herson, D.S., 2001:
Methyl tertiary-butyl ether inhibits toluene degradation by Pseudomonas putida mt-2

Callahan, B.P.trick; Wolfenden, R., 2002:
Methyl transfer between amines A new biomimetic reaction

Zhou, Z.S.; Smith, A.E.; Peariso, K.; Penner Hahn, J.E.; Matthews, R.G., 2000:
Methyl transfers to thiols The role of zinc

Vasquez Vivar, J.; Martasek, P.; Karoui, H.; Kalyanaraman, B., 2000:
Methyl viologen but not 1-methyl-4-phenylpyridinium is reduced by neuronal nitric oxide synthase to generate superoxide anion

Vasquez Vivar, J.; Martasek, P.; Karoui, H.; Kalyanaraman, B., 2000:
Methyl viologen but not 1-methyl-4-phenylpyridinium is reduced by the reductase domain of neuronal nitric oxide synthase to generate superoxide anion

Rubin, D.; Horvath, D.M.; Ismail Beigi, F., 2002:
Methyl- -cyclodextrin inhibits the activation of glucose transport by azide

End, D.W.lliam; Zelesko, M.J., 2002:
Methyl-2-quinolinone derivatives as inhibitors of smooth muscle cell proliferation

Hamasaki, Yuhei; Zaitu, Masafumi; Tsuji, Kosuke; Miyazaki, Michiko; Hayasaki, Rika; Muro, Eriko; Yamamoto, Shuichi; Kobayashi, Ikuko; Matsuo, Muneaki; Ichimaru, Tomohiro; Miyazaki, Sumio, 2000:

Straetling, W.H.; Yu, F.; Thiesen, J.; Buschdorf, J., 2000:
Methyl-CPG-binding protein 2 Role in development and gene expression

Shiraishi, M.; Sekiguchi, A.; Oates, A.J.; Terry, M.J.; Miyamoto, Y.; Sekiya, T., 2004:
Methyl-CpG binding domain column chromatography as a tool for the analysis of genomic DNA methylation

Diederichs, S.; Muller, C.; Idos, G.E.; Berdel, W.E.; Serve, H., 2000:
Methyl-CpG binding domain proteins are abundantly expressed in human cancer cell lines despite tissue-restricted expression in the healthy organism

Patra, S.K.; Patra, A.; Carroll, P.; Dahiya, R., 2002:
Methyl-CpG-DNA binding proteins in human prostate cancer

Van den Veyver, I.B.; Zoghbi, H.Y., 2000:
Methyl-CpG-binding protein 2 mutations in Rett syndrome

Jost Paquin, K.; Thompson, C.M.; Francis, S.; Schneeberger, E.E.; Lynch, R.D., 1999:
Methyl-beta-cyclodextrin induced changes in phospholipase D activity are coincident with alterations in transepithelial electrical resistance of MDCK cell monolayers

Tsujikawa, H.; Masumiya, H.; Song, Y.; Ochi, R., 2004:
Methyl-beta-cyclodextrin intracellularly depresses beta-adrenergic enhancement of L-type calcium current in rabbit ventricular myocytes

John, T.A.; Minshall, R.D.; Tiruppathi, C.; Malik, A.B., 2001:
Methyl-beta-cyclodextrin-sensitive albumin uptake and efflux in endothelial cells

Ragsdale, S.W.; Horng, Y.C.ern; Singh, K.; Kunz, R.; Maroney, M.J.; Bocian, D.F.; Tang, Q.; Carrington, P.E.; Telser, J.; Hoffman, B.M., 2003:
Methyl-coenzyme M reductase and coenzyme F430 Bioorganometallic chemistry?

Chou, M.W.; Aidoo, A.; Mikhailova, M.V.; Nichols, J.; Casciano, D.A., 1999:
Methyl-deficiency and dietary restriction on modulated aflatoxin B1-induced splenic lymphocyte Hprt mutation and spleen telomerase activity in rats

Zhu, K.; Davidson, N.; Hunter, S.; Yang, X.; Payne Wilks, K.; Roland, C.; Phillips, D.; Bentley, C.; Dai, M.; Williams, S., 2003:
Methyl-deficient diets and risk of breast cancer among African-American women A case-control study by methylation status of the estrogen receptor genes

Lembert, N.; Joos, H.C.; Ammon, H.P.T.; Wahl, M.A., 1999:
Methyl-pyruvate initiates insulin release by a KATP+-channel independent mechanism

Yin, M.; Yancey, P.H., 2000:
Methylamine osmolytes dominate in deep-sea polychaetes, pycnogonids, and octopods

Liu, Z.; Liu, M.; Liu, M.; Li, J., 2010:
Methylanthraquinone from Hedyotis diffusa WILLD induces Ca(2+)-mediated apoptosis in human breast cancer cells

Toyota, M.; Issa, J-Pierre.J., 2002:
Methylated CpG island amplification for methylation analysis and cloning differentially methylated sequences

Zhu, W.G.o; Dai, Z.; Srinivasam, K.; Ding, H.; Duan, W.; Villalona, M.; Plass, C.; Otterson, G.A., 2002:
Methylated Sp1 binding sites are responsible for p21 silencing

Soukara, S.; Maier, C.A.; Predoiu, U.; Ehret, A.; Jackisch, R.; Wuensch, B., 2001:
Methylated analogues of methyl -4- -3- piperazine-1-carboxylate as highly potent kappa-receptor agonists Stereoselective synthesis, opioid-receptor affinity, receptor selectivity, and functional studies

Schmiegelow, K.; Nygaard, U., 2003:
Methylated metabolites of 6-mercaptopurine are associated with hepatotoxicity in childhood leukemia

Schneider, Y.; Chabert, P.; Launay, J.F.ancois; Coehlo, D.; Fougerousse, A.; Gosse, F.; Fischer, B.; Bischoff, P.; Brouillard, R.; Raul, F., 2002:
Methylated resveratrol A new antimitotic drug interacting with microtubules

Meheus, L.; Union, A.; Raymackers, J.; Luhrmann,, 2002:
Methylated, SMD homologous peptides, reactive with the antibodies from sera of living beings affected with systemic lupus erythematosus

Metzelaar, J.W.; Van Der Velden, P.A.; Gruis, N.A.; Hurks, H.M.; Ksander, B.R.; Jager, M.J., 1999:
Methylation A major cause of P16/CDKN2A inactivation in uveal melanoma

Szabó, P.E.; Mann, J.R.; Pfeifer, G.P., 2002:
Methylation analysis by chemical DNA sequencing

Hofmann, W.K.; Tsukasaki, K.; Takeuchi, N.; Takeuchi, S.; Koeffler, H.P., 2001:
Methylation analysis of cell cycle control genes in adult T-cell leukemia/lymphoma

Wylie, A.A.; Cotter, P.D.; Williford, B.; Papenhausen, P.R.; Jirtle, R.L., 2001:
Methylation analysis of maternal and paternal uniparental disomy of human chromosome 14

Tago, O.; Fujiwara, H.; Ito, M., 1999:
Methylation analysis of patched gene promoter in basal cell carcinoma

Shridhar, V.; Staub, J.; Smith, D.I.; Jett, J.R., 1999:
Methylation analysis of sputum from smokers lungs

Newberry, S.T.; White, K.K.; Coleman, W.B., 2003:
Methylation analysis of the BRCA1 promoter in human breast cancer cell lines

Kikuchi, T.; Toyota, M.; Suzuki, H.; Yamamoto, H.; Hideki, K.; Itoh, F.; Issa, J.J.; Imai, K., 2000:
Methylation analysis of the COX-2 gene in gastrointestinal tumors

Mihara, M.; Inada, K.I.hi; Tsukamoto, T.; Imai, K.; Sugimura, T.; Tatematsu, M.; Ushijima, T., 2002:
Methylation analysis of the CpG islands in the promoter regions of the Cdx1, Cdx2 and SOX-2 genes in intestinal metaplasia of the human stomach

Tassone, F.; Sahota, P.; Pleasant, N.; Laird, C.; Hagerman, P., 2002:
Methylation analysis of the promoter region in fragile X males with hypermethylated, full mutation alleles

Zalduendo, M.M.r; Boyano, D.; Feil, R.; Andollo, N.; Arechaga, J., 2001:
Methylation and chromatin conformation in the U2af1-rs1 imprinted gene in the male germ cell line

Chevassut, T.; Forrester, L.; Ansell, J.; Lim, B., 2001:
Methylation and differentiation Cause or effect? Development of an inducible system to study the role of DNA methylation on the differentiation of murine embryonic stem cells

Mehrotra, J.; Ganpat, M.M.chelle; Kanaan, Y.; Mcveigh, M.; Mulvey, C.; Fackler, M.J.; Argani, P.; Lahti Domenici, J.; Polyak, K.; Naab, T.; Broome, C.; Sukumar, S., 2003:
Methylation and expression profiling of African American and Caucasian breast cancer

Liu, F.; Sui, J.L.; Zhou, P.K.n, 2003:
Methylation and suppressed expression of p14ARF gene in malignant transformed BEP2D cells induced by alpha-particle exposure

Hinits, Y.; Lavy, M.; Moav, B., 2002:
Methylation and transgene expression in transgenic common carp

Jelinek, J.; Prchal, J.T.; Issa, J.P.erre, 2003:
Methylation at CpG islands of tumor-associated genes in polycythemia vera

Hoare, S.F.; Bryce, L.; Muir, S.; Keith, W.N., 2000:
Methylation at the telomerase RNA gene promoter, induces alternative methods of telomere length maintenance in human cells

Vlasova, T.I.; Chou, M.; Wise, C.; Vanyushin, B.; Poirier, L.A., 2001:
Methylation by DNA methyltransferase of endogenous DNA in nuclear extracts from preneoplastic rat livers

Minko, I.; Hattman, S.; Lloyd, R.S.ephen; Kossykh, V., 2001:
Methylation by a mutant T2 DNA methyltransferase expands the usage of RecA-assisted endonuclease cleavage

Esteller, M., 2003:
Methylation changes in cell biology

Lind, G.E.isabeth; Kleivi, K.; Thorstensen, L.; Hamelin, R.; Teixeira, M.R.; Lothe, R.A., 2003:
Methylation characteristics of a panel of colon carcinoma cell lines

Stead, L.M.; Au, K.P.; House, J.D.; Brosnan, M.E.; Brosnan, J.T., 2000:
Methylation demand and the control of homocysteine metabolism

Witt, V.; Price, E.A.; Pritchard, K.; Onadim, Z., 2002:
Methylation detection in the promoter for retinoblastoma

Buiting, K.; E.M.arri, O.; Peery, E.G.; Kroisel, P.M.; Balaban, B.; Wagner, K.; Urman, B.; Heyd, J.; Lich, C.; Brannan, C.I.; Walter, J.; Horsthemke, B., 2001:
Methylation imprints on human chromosome 15 are established around or after fertilization

Brothman, A.R.; Cui, J.; Maxwell, T.; Niveleau, A., 2002:
Methylation in prostate cancer Is this as important as it gets?

Herman, J.; Esteller, M.; Corn, P.; Baylin, S., 1999:
Methylation inactivates critical pathways in tumourgenesis

Harrington Brock, K.; Winkfield, E.; Mass, M.J., 2002:
Methylation inactivates pentavalent arsenic species but activates trivalent arsenic species to potent genotoxicants

Deng, G.; Pong, E.; Song, G.A.; Kim, Y.S., 2002:
Methylation interferes with the binding between CCAAT box of APC promoter and the transcription factor CBF resulting in gene silencing in colorectal cancer

Singal, R.; Vanwert, J.M.; Ferdinand, L., 2003:
Methylation is dominant over histone deacetylation in silencing Glutathione S-Transferase P1 gene expression in prostate cancer cells

Siedow, A.; Gratchev, A.; Hanski, M.L.; Riecken, E.O.; Hanski, C., 1999:
Methylation is the main regulatory mechanism for MUC2 gene expression in carcinoma cell lines of colon, breast, and pancreas

de Capoa, A.; Grappelli, C.; Febbo, F.R.; Spanò, A.; Niveleau, A.; Cafolla, A.; Cordone, I.; Foa, R., 1999:
Methylation levels of normal and chronic lymphocytic leukemia B lymphocytes: computer-assisted quantitative analysis of anti-5-methylcytosine antibody binding to individual nuclei

Siegfried, Z.; Shteper, P.J.; Asimakopoulos, F.A.; Palumbo, G.A.; Rachmilewitz, E.A.; Ben Neriah, Y.; Ben Yehuda, D., 1999:
Methylation of ABL1 in acute lymphatic leukemia

Walsh,; Nishio, H.; Li, S., 2003:
Methylation of CCAAT displacement protein/cut by CARM1 is associated with derepression of c-myc and cyclin D1

Zhao, H.; Wong, R.J.; Mizobuchi, M.; Stevenson, D.K.; Contag, C.H., 2004:
Methylation of CpG islands in the transcriptional regulation of heme oxygenase-1 in the developing brain

Scott, S.; Ichinohasama, R.; Fan, X.; Sheridan, D.P.; Mccaslin, J.; Lowsky, R.; Decoteau, J.F., 1999:
Methylation of CpG sites in a small region of the hMSH2 promoter is associated with loss of detectable protein

Scott, S.A.; Kimura, T.; Ichinohasama, R.; Sheridan, D.P.; Decoteau, J.F., 2000:
Methylation of CpG sites within the p27KIP1 and p21WAF1 promoters is not associated with loss of detectable p27KIP1 and p21WAF1 mRNA in human AML

Archey, W.B.; Sweet, M.P.; Alig, G.; Douville, K.; Arrick, B.A., 1999:
Methylation of CpGs as a determinant of transcriptional activation at two promoters in transforming growth factor-beta3

Chan, A.O.O.; Lam, S.K.m; Wong, B.C.un Yu; Hui, W.M.; Kwong, Y.L.m, 2002:
Methylation of E-cadherin gene in gastric cancer and in normal gastric mucosa from patients with and without Helicobacter pylori infection

Deshmane, V.H.; Droufakou, S.; Hanby, A.M.; Harris, W.H.; Fentiman, I.S.; Hart, I.R., 1999:
Methylation of E-cadherin promoter is a frequent event in invasive breast cancer

Ehrlich, M.; Tsien, F.; Figlewicz, D.; Winokur, S., 2000:
Methylation of FSH muscular dystrophy-associated DNA repeats

Akiyama, Y.; Suzuki, H.; Yuasa, Y.; Herman, J.G.; Baylin, S.B., 2002:
Methylation of GATA transcription factors in gastrointestinal cancer

Bassi, C.; Riva, P.; Marozzi, A.; Conti, A.M.; Ginelli, E.; Meneveri, R., 1999:
Methylation of GC-rich beta satellite blocks in human tissue

Patel, K.; Maclennan, K.; Selby, P.J.; Burchill, S., 2002:
Methylation of GSTP-1, CD44, e-cadherin and RASSF1A in normal and malignant prostate tissue

Murakami, J.; Asaumi, J.I.hi; Matsubara, N.; Iwagaki, H.; Isozaki, H.; Tanaka, N.; Kishi, K., 2002:
Methylation of O6-methylguanine-DNA methyltransferase in upstream promoter, not in the untranslated first exon, is responsible for aberrant silencing and for biological effect against alkylating agents

Yu, H.; Singal, R.; Smith, M.; Glass, J.; Li, B., 2001:
Methylation of P16 in peripheral blood cells and breast cancer

Loginov, W.; Senchenko, V.; Malyukova, A.; Bazov, I.; Kazubskaya, T.; Ermilova, V.; Garkavtseva, R.; Kashuba, V.; Zabarovsky, E.; Braga, E., 2002:
Methylation of RASSF1A promoter region and deletion aberrations around this TSG in epithelial carcinomas

Rim, J.S.; Mccabe, R.L.; Mancuso, J.J.; Kozak, L.P., 2001:
Methylation of RhoGAP in white adipose tissues and associated UCP1 induction

Malyukova, A.; Kilosanidze, G.; Loginov, W.; Bazov, I.; Kashuba, V.; Ermilova, V.; Kazubskaya, T.; Garkavtseva, R.; Zabarovsky, E.; Braga, E., 2002:
Methylation of SEMA3B and new candidate TSGs in D3S2409-D3S2456 in chromosome 3p2131

Beever, C.; Lai, B.P.Y.; Baldry, S.E.L.; Peñaherrera, M.S.; Jiang, R.; Robinson, W.P.; Brown, C.J., 2003:
Methylation of ZNF261 as an assay for determining X chromosome inactivation patterns

Sekiya, T.; Koizume, S.; Hirohashi, S.; Shiraishi, M., 2001:
Methylation of a CpG island associated with the E-cadherine gene silencing in human cancer cells

Wiencke, J.K.; Zheng, S.; Smith, M.; Zhang, L.; Ma, X.; Wiemels, J.; Marsit, C.; Kelsey, K.; Buffler, P., 2003:
Methylation of a transcribed PTEN pseudogene in pediatric leukemia is associated with subtypes of common ALL containing t translocation

Singal, R.; Vanwert, J.M., 2001:
Methylation of alpha-type embryonic globin gene alphapi suppresses transcription in primary erythroid cells

Kimura, T.; Scott, S.A.; Ichinohasama, R.; Kerviche, A.; Sheridan, D.P.; Decoteau, J.F., 2001:
Methylation of components in the transforming growth factor-beta growth arrest pathway in human T-cell lymphoblastic lymphoma

Matsubayashi, H.; Sato, N.; Fukushima, N.; Yeo, C.J.; Walter, K.M.; Brune, K.; Hruban, R.H.; Su, G.H.; Goggins, M., 2003:
Methylation of cyclin D2 is frequently observed in pancreatic cancer but is also an age-related phenomenon in gastrointestinal tissues

Lin, C.; Zhang, N.; Huang, X.; Kolbanoviskiy, A.; Hingerty, B.E.; Broyde, S.; Geacintov, N.E.; Patel, D.J., 2003:
Methylation of cytosine in a C- G sequence context selectively switches the conformation of -trans-anti- G adduct, but not its -trans-anti-counterpart, from a minor groove alignment of the BP adduct, to intercalation with a base displacement alignment

Fujii, S.; Takeda, J.; Kitajima, K.; Itabashi, M.; Kameoka, S.; Nakamura, T.; Terano, A.; Chiba, T.; Fujimori, T., 2003:
Methylation of estrogen receptor gene in nonneoplastic epithelium as a marker of colorectal neoplasia risk in ulcerative colitis

Mac, S.M.; Czekay, S.M.; Boyer, A.D.; Cavenee, W.K.; Arden, K.C., 2002:
Methylation of genes in prostate cancer Possible prognostic significance

Salvesen, H.B.; Macdonald, N.; Ryan, A.; Iversen, O.E.; Jacobs, I.J.; Akslen, L.A.; Das, S., 2000:
Methylation of hMLH1 indicates a distinct pathway in endometrial cacinogenesis

Bartova, E.; Kozubek, S., 2003:
Methylation of histone H3 lys 4 and gene activity in human leukemic cells undergoing differentiation

Green, H.A.; Ballard, S.L.; Ross, D.J.; Mitnick, J.J., 2000:
Methylation of homocysteine to methionine by 5-methyltetrahydrofolate

Lucifero, D.; Mertineit, C.; Clarke, H.J.; Bestor, T.H.; Trasler, J.M., 2001:
Methylation of imprinted genes in the germ line

Vahter, M., 1999:
Methylation of inorganic arsenic in different mammalian species and population groups

Yau, L.M.; Li, C.W.; Li, H.M.; Liew, C.T., 2001:
Methylation of multiple genes in hepatocellular carcinoma

He, Y.J.; Yagi, H.; Jerina, D.M.; Cheh, A.M., 1999:
Methylation of nearest neighbor cytosines and the ratio of 1S vs 1R adducts formed by three isomers of 3,4-dihydroxy-1,2-epoxy-1,2,3,4-tetrahydrobenzo phenanthrene

Boldyrev, A.A.; Leinsoo, T.A.; Abe, H., 2002:
Methylation of neuropeptide carnosine modifies its protecting but not antioxidant properties

Chim, C.S.; Tam, C.Y.Y.; Liang, R.; Kwong, Y.L., 2000:
Methylation of p15 and p16 genes in adult acute leukemia

Huh, J.; Yoo, E.; Seoung, C.; Chung, W., 2003:
Methylation of p15 gene in acute leukemia patients

Molfetta, G.A.; Lima, P.S.P.; Passos, M.V.S.; Silva, W.A.J., 2003:
Methylation of p15 tumor-supressor gene in familial and sporadic malignant melanoma

Divine, K.K.; Gilliland, F.D.; Stidley, C.A.; Bocklage, T.J.; Schwartz, A.; Cook, D.L.; Belinsky, S.A., 2001:
Methylation of p16 in central and peripheral human lung adenocarcinoma

Li, X.; Hui, A.M.; Sun, L.; Mafune, K.; Takayama, T.; Makuuchi, M., 2001:
Methylation of p16INK4 is a frequent event but not associated with transcriptional silencing and protein absence in human hepatocellular carcinoma

Park, T.J.n; Kim, H.S.ok; Yun, G.; Jang, J.J.n; Lim, I.K.oung, 2000:
Methylation of p16INK4a and p15INK4b promoter is a late event in the hepatocarcinogenesis induced by diethylnitrosamine and thioacetamide in fischer 344 male rats

Fernandez D.V.lasco, J.; Llamas, P.; Diaz, M.A.; Madero, L.; Loscertales, J.; Tomas, J.F., 2000:
Methylation of p16INK4a in children with acute lymphoblastic leukemia at diagnosis

Hyun, Y.L.; Park, S.H.; Lew, D.B.; Williams, K.R.; Park, G.H.; Paik, W.K.; Kim, S., 1999:
Methylation of peptides derived from two GRG-containing proteins by S-adenosylmethionine Protein arginine N-methyltransferase

Youssef, E.M.; Issa, J.P.erre; Mao, L.; Hong, W.K.; Lotan, R., 2001:
Methylation of retinoic acid receptor beta in head and neck squamous cell carcinoma cell lines and tumors

Virmani, A.K.; Rathi, A.; Zoechbauer Mueller, S.; Sacchi, N.; Fong, K.M.; Geradts, J.; Minna, J.D.; Gazdar, A.F., 2000:
Methylation of retinoic acid receptor beta in lung cancer tumors and cell lines

Lee, E.Y.; Huynh, L.; Lamango, N.S.; Chen, H.; Shepherd, K.; Zhao, W.; Lambert, A.; Charlton, C.G., 2001:
Methylation of striatal and cloned D1 and D2 dopamine receptor proteins

Jameson, R.R.; Carlson, B.A.; Hatfield, D.L.; Diamond, A.M., 2004:
Methylation of tRNA Sec in the regulation of selenoprotein synthesis

Tepper, S.; Butz, G.M.; Grisham, J.W.; Coleman, W.B., 2001:
Methylation of the BRCA1 promoter accounts for loss of gene expression during rat hepatocarcinogenesis

Wei, M.J.e; Grushko, T.; Das, S.; Dignam, J.; Hagos, F.; Sveen, L.; Fackenthal, J.; Olopade, O.I., 2003:
Methylation of the BRCA1 promoter in sporadic breast cancer related to BRCA1 copy number and pathologic features

Rice, J.C.; Ozcelik, H.; Andrulis, I.L.; Holtan, N.; Futscher, B.W., 2000:
Methylation of the BRCA1 promoter is associated with decreased BRCA1 expression in clinical breast cancer specimens

Jung, K.Y.; Phan, B.P.; Takebayashi, S.; Fearon, E.R.; Choi, J.O.; E.N.ggar, A.K.; Carey, T.E., 1999:
Methylation of the DCC gene in squamous cell carcinoma

Friedrich, M.G.; Liang, G.; Toma, M.I.; Weisenberger, D.J.; Cheng, J.C.; Siegmund, K.D.; Huland, H.; Jones, P.A., 2004:
Methylation of the E-Cadherin and the TIMP-3 genes are positive prognostic markers for patients with non-muscle invasive bladder carcinoma

Rood, B.R.; Zhang, H.; Cogen, P.H., 2003:
Methylation of the MGMT DNA repair gene is common and heterogeneous in childhood medulloblastoma

Andion, E.; Esteller, M.; Jimenez, E.; Martin Algarra, S.; Brugarolas, A.; Garcia Foncillas, J., 2000:
Methylation of the MGMT and MLH1 promoter in high-grade gliomas

Wang, J.C.; Chen, W.; Nallusamy, S.; Chen, C., 1999:
Methylation of the P15INK4b and p16INK4a in agnogenic myeloid metaplasia and AMM in leukemic transformation

Han, M.K.; Butler, M.G.; Sutcliffe, J.S., 1999:
Methylation of the UBE3A CpG island does not mediate transcriptional repression of the paternal allele in brain

Bigler, J.; Yasui, Y.; Lampe, J.W.; Potter, J.D., 2000:
Methylation of the estrogen receptor Variation across colonic subsites in epithelium and stroma

Phillips, B.; Navari, J.R.; Lee, R.Y.; Roland, P.Y., 1999:
Methylation of the estrogen receptor gene is not an early event in endometrial tumorigenesis

Kurmasheva, R.K.; Cooney, C.A.; Peterson, C.A.; Parham, D.M., 2003:
Methylation of the human PAX3 upstream region in rhabdomyosarcomas

Asano, T.; Asano, A.T.utsuda, 2001:
Methylation of the human topoisomerase IIa gene promoter might be associated with decreased expression of topoisomerase IIa in etoposide-resistant MDA-VP cells

Toppings, M.; Trasler, J.M., 2003:
Methylation of the imprinted gene Snrpn in blastocysts from naturally cycling and superovulated mice

Diederich, M.F.; Borde Chiche, P.; Dicato, M., 2000:
Methylation of the minimal promoter of the glutathione S-transferase P1 gene regulates transcription in human leukemia cells

Bobo, W.; Stone, A.; Brat, D.; Devi, S.N.; Van Meir, E.; Vertino, P.M., 2002:
Methylation of the novel apoptotic gene TMS1/ASC in human glioblastoma multiforme

Mateos, M.V.; Garcia Sanz, R.; Lopez Perez, R.; Moro, M.J.; Lopez, R.; Hernandez, J.; Megido, M.; Caballero, M.D.; Fernandez Calvo, J.; Barez, A.; Almeida, J.; Orfao, A.; Gonzalez, M.; San Miguel, J.F., 2000:
Methylation of the p16 gene is associated with high plasma cell proliferation and short survival in multiple myeloma

Schneider Stock, R.; Giers, A.; Motsch, C.; Boltze, C.; Freigang, B.; Roessner, A., 2003:
Methylation of the p16INKdollar sign promotor as the second genetic hit in patient with multiple head and neck cancer bearing a hereditary p16-Leiden mutation

Krichevsky, S.; Siegfried, Z.; Asimakopoulos, F.A.; Shteper, P.J.; Goldschmidt, N.; Rachmilewitz, E.A.; Rund, D.; Ben Yehuda, D., 1999:
Methylation of the promoter regions of DNA repair and genotoxic stress response genes in therapy-related but not primary leukemia

Katsaros, D.; Cho, W.; Singal, R.; Fracchioli, S.; D.L.L.ngrais, I.A.R.gault; Puopolo, M.; Smith, M.; Zheng, W.; Glass, J.; Yu, H., 2003:
Methylation of tumor suppressor gene p16 and epithelial ovarian cancer survival

Pascali, C.; Bogni, A.; Iwata, R.; Cambie, M.; Bombardieri, E., 2000:
Methylation on a C18 Sep-Pak cartridge A convenient way to produce choline

Dansranjavin, T.; Tannapfel, A.; Wittekind, C.; Hauss, J.; Witzigmann, H., 2003:
Methylation pattern of E-cadherin and DAP kinase in pancreatic adenocarcinoma and corresponding lymph node metastases

Bussey, K.J.; Lawce, H.J.; Olson, S.B.; Shu, X.O.; Magenis, R.E., 1999:
Methylation pattern of SNRPN exon 1 in germ cell tumors Assessing loss of imprinting in cancer

Lage, P.A.; Cravo, M.L.; Maia, L.; Claro, I.M.; Chaves, P.P.; Albuquerque, C.M.; Gaspar, C.; Nobre Leitao, C.A., 2000:
Methylation pattern of hMLH1 and microsatellite instability in sporadic colorectal cancers

Yoo, H.W.; Kim, S.S.; Kim, G.H., 2002:
Methylation pattern of human GRB10 gene in patients with Silver-Russell syndrome or intrauterine growth retardation

Shimamoto, T.; Ando, K.; Kurakawa, E.; Ohyashiki, J.H.; Ohyashiki, K., 2001:
Methylation pattern of p15INK4b and E-cadherin genes is associated with prognosis in acute myeloid leukemia

Sieglova, Z.; Honzatkova, L.; Rihova, H.; Cermak, J.; Brdicka, R., 1999:
Methylation pattern of the calcitonin gene, microsatellite instability, and mutations of N-Ras oncogene in myelodysplastic syndromes

Milsted, A.; Kirk, D.; Marcelo, M.; Turner, M.; Ely, D., 2000:
Methylation pattern shifts in the androgen receptor gene coincide with altered expression of androgen-responsive genes in SHR/y and WKY female rats

Reinhold, W.C.; Maunakea, A.K.; Kim, S.; Stewart, C.; Lababidi, S.; Kouros Mehr, H.; Cui, H.; Bussey, K.; Pommier, Y.; Munroe, D.; Feinberg, A.; Weinstein, J.N., 2003:
Methylation patterns and correlation to transcript levels for the NCI60 cancer cell lines for E-cadherin

Bell, A.L.uise; Shriver, S.P.rsinger; Siegfried, J.M., 2001:
Methylation patterns in the promoter region of the GRPR gene in humans

Weinshilboum, R.M.; Otterness, D.M.; Szumlanski, C.L., 1999:
Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase

Von Hippel, S.; Hermes, M.; Osswald, H.; Kloor, D., 2004:
Methylation potential in four different cell lines

Aranyi, T.; Fauchex, B.A.; Faucon, B.N.; Mallet, J.; Meloni, R., 2000:
Methylation profile of a CpG island in the human tyrosine hydroxylase gene

Pichardo, D.; Levenson, V.; Ma, C.; Krett, N.; Rosen, S., 2003:
Methylation profile of multiple myeloma cell lines A high throughput screening assay

Brentzell, L.M.rion; Campbell, I., 2002:
Methylation profile of tumor suppressor genes in breast and ovarian cancer

Jair,; Toyota, M.; Toyota, M.O.e; Ho, C.; Baylin, S.B.; Issa, J.P.erre J., 2000:
Methylation profiles of randomly selected genes in human cancer

Bai, A.H.; Tong, J.H.; Man, E.P.; Chan, M.W.; To, K.F.i; Sung, J.J.; Leung, W.K., 2003:
Methylation profiles of sporadic colorectal cancer and adenoma

Pu, R.T.; Laitala, L.E.; Clark, D.P., 2003:
Methylation profiles to differentiate benign and malignant breast lesions in surgical and cytological specimens

Broaddus, R.R.; Issa, J.P.J., 2002:
Methylation profiling in low-grade endometrial endometrioid adenocarcinomas

Akey, D.T.; Akey, J.M.; Reveille, J.D.; Jin, L., 2002:
Methylation profiling of CpG islands spanning the MHC class II region and HLA-B in ankylosing spondylitis cases and controls

Wagner, K.J.; Morgan, N.V.; Lees, R.D.; Morris, M.R.; Cooper, W.N.; Grundy, R.G.; Macdonald, F.; Latif, F.; Maher, E.R., 2002:
Methylation profiling of Wilms tumour and adult renal cell carcinoma

Habuchi, T.; Wang, L.; Akao, T.; Sato, S.; Sato, K.; Kato, T.; Takahashi, T.; Ogawa, O., 2000:
Methylation profiling of a bladder cancer tumor suppressor region at chromosome 9q32-33

Huang, T.H.i Ming; Perry, M.R.; Laux, D.E., 1999:
Methylation profiling of an archipelago of CpG islands in human breast cancer cells

Deshmane, V.H., 2002:
Methylation profiling of solid tumours

Maier, S.; Lesche, R.; Haefliger, C.; Nimmrich, I.; Burger, M.; Lipscher, E.; Adorjan, P.; Lofton Day, C.; Sledziewski, A.; Berlin, K.; Olek, K., 2003:
Methylation profiling to identify colon cancer markers for early detection of disease

Ramkumar, M.; Kolli, M.K.; Edinger, R.S.; Kleyman, T.R.; Johnson, J.P., 2002:
Methylation regulates epithelial sodium channel in Xenopus oocytes

Haaf, T.; Dirim, F.; Stojkovic, M.; Zakhartchenko, V.; Wolf, E.; Shi, W., 2003:
Methylation reprogramming and chromosomal aneuploidy in cloned rabbit embryos

Hermann, A.; Jeltsch, A., 2003:
Methylation sensitivity of restriction enzymes interacting with GATC sites

Battagli, C.; Krassenstein, R.; A.S.leem, T.; Greenberg, R.E.; Uzzo, R.G.; Cairns, P., 2002:
Methylation specific PCR-based detection of renal cell carcinoma in urine

Vanwert, J.M.; Singal, R., 2000:
Methylation spreading and strand-specificity of de novo methylation of an embryonic globin gene during normal development

Jimenez, E.; Garcia Foncillas, J.; Salgado, E.; Okroujnov, I.; Angeletti, S.; Huarriz, M.; Andion, E.; Guzman, M.; Schneider, J.; Brugarolas, A., 1999:
Methylation status assay of p16 and p15 promoters by methylation-specific PCR in epithelial ovarian cancer

Tada, Y.; Wada, M.; Nakayama, M.; Harada, T.; Nagayama, J.; Kurolwa, K.; Tuneyoshi, M.; Nakagawa, M.; Naito, S.; Kuwano, M., 2000:
Methylation status of CPG sites at the promoter region and expression of MDR1 in patients with bladder cancer

Sakamoto, Y.; Kitazawa, R.; Aoyama, N.; Maeda, S.; Kitazawa, S., 1999:
Methylation status of CpG island of adenomatous polyposis coli gene and its relationship to gene expression in colon cancer cell lines

Azarschab, P.; Porschen, R.; Blin, N.; Holzmann, K., 2001:
Methylation status of E-cadherin in colitis ulcerosa patients

Horan, M.; Upadhyaya, M., 1999:
Methylation status of NF1 promoter in benign tumours from 10 unrelated NF1 patients

Graziani, D.; Ghisini, R.; Romagnoli, S.; Maggioni, M.; Sirchia, S.; Sacchi, N.; Bonavina, L.; Peracchia, A.; Bosari, S.; Coggi, G., 2002:
Methylation status of RARbeta2 promoter in esophageal cancer

Deshmane, V.H.; Droufakou, S.; Hanby, A.M.; Harris, W.H.; Fentiman, I.S.; Hart, I.R., 2000:
Methylation status of p16 in breast cancer cell lines, normal breast tissue, breast tumours and lymphocytes

Lin, L.I.; Chen, H.C.en; Tang, J.L.h; Li, D.K.n; Wang, C.H.a; Tien,, 2003:
Methylation status of the DAPK gene in myelodysplastic syndrome A high frequency of the gene methylation in chronic myelomonocytic leukemia

Schuchardt, K.; Neumann, S.; Reske, A.; Paschke, R., 2000:
Methylation status of the Na+/I--symporter promotor region in benign cold thyroid nodules

Pakneshan, P.; Guo, Y.; Tetu, B.; Rabbani, S.A., 2002:
Methylation status of uPA promoter in surgical biopsy specimens of breast cancer patients is a highly accurate molecular marker for disease progression

Bariol, C.; Suter, C.; Ku, S.L.; Cheong, F.K.; Meagher, A.; Ward, R., 2004:
Methylation studies in colonic polyps and cancers

Osborn, M.J.; Cooper, D.N.; Upadhyaya, M., 1999:
Methylation studies in facioscapulohumeral muscular dystrophy

Chen, C.M.; Chen,; Yan, P.S.; Huang, T.H.i Ming, 2002:
Methylation tissue array A novel technique for simultaneous analysis of extensive DNA hypermethylation in multiple breast tumors

Egorov, E.E.; Veiko, N.N.; Tsvetkova, T.G.; Terekhov, S.M.; Karachentsev, D.N.; Vishnyakova, K.S.; Smirnova, T.D.; Lyapunova, N.A.; Zelenin, A.V., 2002:
Methylation, copy number, and the activity of ribosomal genes do not change after Telomerization of human fibroblasts

Garinis, G.A.; Menounos, P.; Spanakis, N.; Patrinos, G.P.; Papadopoulos, G.; Karavitis, G.; Peros, G., 2002:
Methylation-associated transcriptional silencing of E-cadherin in association with beta-catenin expression in sporadic colorectal carcinomas

Yang, X.; Blum, J.; Phillips, D.L.; Herman, J.G.; Davidson, N.E., 2002:
Methylation-mediated hypoactylation of histones H3 and H4 is associated with silencing of estrogen receptor-alpha in human ER-negative breast cancer cells

Stimson, K.M.rie; Fowler, K.A.; Vertino, P.M., 2001:
Methylation-mediated silencing of TMS1 is accompanied by local changes in chromatin structure and histone hypoacetylation

Fujita, N.; Takebayashi, S.; Okumura, K.; Matsui, S.; Kudo, S.; Chiba, T.; Saya, H.; Nakao, M., 2000:
Methylation-mediated transcriptional regulation and chromatin structure by methyl-CpG binding protein MBD1 isoforms

Fonsatti, E.; Sigalotti, L.; Coral, S.; Colizzi, F.; Altomonte, M.; Maio, M., 2003:
Methylation-regulated expression of HLA class I antigens in melanoma

Weinhaeusel, A.; Skarits, C.; Haas, O.A., 2000:
Methylation-sensitive PCR analysis of the fragile X syndrome

Strelnikov, V.; Zemlyakova, V.; Artamonov, V.; Vasil'ev, E., 2002:
Methylation-sensitive multiplex FRAXA-FRAXE PCR assay is a powerful non-invasive neonatal screening method capable of detecting genetic abnormalities in 1500 newborn boys

Kaneda, A.; Takai, D.; Kaminishi, M.; Okochi, E.; Ushijima, T., 2003:
Methylation-sensitive representational difference analysis and its application to cancer research

Davies, C.S., 2002:
Methylation-sensitive restriction fingerprinting

Goessl, C.; Mueller, M.; Heicappell, R.; Krause, H.; Straub, B.; Miller, K., 2001:
Methylation-specific PCR for DNA-based detection of prostatic neoplasia in washings of transrectal prostate biopsy samples

Gitan, R.S.; Shi, H.; Chen, C-Mu.; Yan, P.S.; Huang, T.Hui-Ming., 2002:
Methylation-specific oligonucleotide microarray: a new potential for high-throughput methylation analysis

Koellermann, J.; Goessl, C.; Mueller, M.; Miller, K., 2003:
Methylation-specific polymerase chain reaction for the detection of occult lymphatic prostate tumor cell dissemination Correlation with immunohistochemical findings

Suzuki, H.; Sekita, N.; Ichikawa, T.; Akakura, K.; Ito, H., 2001:
Methylational status of metastasis suppressor gene KAI1 in human prostate cancer cell lines

Arnold, G.L.; Mooney, R.A.; Mccall, K.B.; Kirby, R.S., 2003:
Methylcitrate/citrate ratio as a predictor of clinical control in propionic acidemia

Kanthasamy, A.; Kitazawa, M.; Kaul, S.; Anantharam, V.; Kanthasamy, A.G., 2003:
Methylcyclopentadienyl manganese tricarbonyl induces apoptosis by PKCdelta dependent activation of NF-kappaB in mesencephalic dopaminergic neuronal cells

Helmlinger, D.; Frater, G.; Muller, U., 2001:

Martinez, P.F.J.; Alken, P.; Juenemann, P., 2000:
Methylen blue as a successful treatment alternative for priapism

Schenk, P.; Madl, C.; Mueller, C.; Rezaie Majd, S., 1999:
Methylen blue for the hepatopulmonary syndrome

Bellamy, M.C.; Young, Y.; Snook, N.; Koelzow, H.; Baumann, J.; Gedney, J.A., 1999:
Methylene blue and haemodynamics of reperfusion injury

D'antonio, D.; D.G.anfilippo, R.; Iacone, A.; Bonfini, T., 1999:
Methylene blue and high intensity light source inducing HCV RNA PCR negativity in plasma of two HCV positive patients

Biel, Merrill A., 2000:
Methylene blue and toluidene blue mediated fluorescence diagnosis of cancer

Erdem, A.; Kerman, K.; Meric, B.; Ozkan, D.; Ozsoz, M., 2000:
Methylene blue as a novel electrochemical hybridization indicator for DNA biosensor

Kulkarni, P.M.; Kinzie, J.L., 1999:
Methylene blue chromendography in the management of gastric misperfusion from hepatic intro-arterial chemotherapy device

Ragunath, K.; Raman, V.S.nkara; Haqqani, M.; Cheung, I.; Krasner, N., 2002:
Methylene blue chromoendoscopy in Barretts oesophagus

Nedvidkova, J.; Haluzik, M.; Nedvidek, J.; Schreiber, V., 1999:
Methylene blue decreases estrogen effect on the nitric oxide content in the male rat anterior pituitary

Duan, Y.; Sahley, C.L.; Muller, K.J., 2003:
Methylene blue disrupts directed migration of microglia to nerve lesions in the leech CNS

Wrubel, K.M.; Maldonado, M.A.; Mccollum, D.N.; Gonzalez Lima, F., 2003:
Methylene blue enhances discrimination learning of rewarded vs Non - rewarded trials in a food search task in rats

Bruchey, A.K.; Riha, P.D.; Gonzalez Lima, F., 2003:
Methylene blue improves brain cytochrome C oxidation

Callaway, N.L.; Munshi, Z.; Riha, P.; Wrubel, K.; Mccollum, D.; Gonzalez Lima, F., 2001:
Methylene blue improves reference memory and reversal in holeboard maze

Sharma, A.N.; Chawla, S.; Nelson, L.; Hoffman, R.S., 2000:
Methylene blue safely and effectively treats methemoglobinemia in a known G6PD deficient patient with hemolytic anemia

Dave, U.; Shousha, S.; Westaby, D., 2000:
Methylene blue staining Is it really useful in Barretts oesophagus?

Gossner, L.; Pech, O.; May, A.; Stolte, M.; Ell, C., 1999:
Methylene blue staining for the detection of dysplasia or mucosal cancer in Barretts esophagus - A prospective trial

Liu, Z.R.; Sargueil, B.; Smith, C.W., 2000:
Methylene blue-mediated cross-linking of proteins to double-stranded RNA

Equitani, F.; Mistretta, G.; Mele, L.; Hortencio, M.; Filoni, V.; Pezone, F.; Moroni, S.; Menichella, G., 2003:
Methylene blue-photoinactivated fresh frozen plasma is an effective and safe treatment for inherited and acquired coagulopathies and bleeding disorders

Williamson, L.M.; Cardigan, R.; Prowse, C.V., 2003:
Methylene blue-treated fresh-frozen plasma: what is its contribution to blood safety?

Taborski, U.; Oprean, N.; Tessmann, R.; Basser, S.; Heidinger, K.; Wieding, J.U., 2000:
Methylene blue/light-treated plasma and the disturbance of fibrin polymerization in vitro and in vivo A randomized, double-blind clinical trial

Gisch, D.J.; Martinez, H.; Miller, M., 2001:
Methylene bridged resins yield enhanced osmotic stability in contacting with organic acid streams

Vreman, H.J.; Wong, R.J.; Bryson, J.G.; Stevenson, D.K., 2001:
Methylene chloride metabolism An in vivo and in vitro model for carbon monoxide generation

Fowkes, G.R.; Lee, A.J.; Hau, C.M.; Cooke, A.; Connor, M.; Lowe, G.D.O., 1999:
Methylene tetrahydrofolate reductase and nitric oxide synthase genes and risks of peripheral arterial disease and coronary heart disease Edinburgh Artery Study

Wiemels, J.L.; Smith, R.N.; Taylor, G.M.lcolm; Eden, O.B.; Alexander, F.E.; Greaves, M.F., 2001:
Methylene tetrahydrofolate reductase polymorphisms affect risk of molecularly-defined subtypes of childhood acute leukemia in varied ways

Wiemels, J.L.; Smith, R.N.; Taylor, G.M.lcolm; Eden, O.B.; Alexander, F.E.; Greaves, M.F., 2000:
Methylene tetrahydrofolate reductase polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia

Leroy, B.P.; Messiaen, L.M.; Kestelyn, P.; D.L.ey, J.J.; Baele, G., 1999:
Methylene-H4-folate reductase TT677 genotype in 4 patients with CRVO/BRVO

Pethig, K.; Hoffmann, A.; Heublein, B.; Wittwer, T.; Haverich, A., 1999:
Methylene-tetrahydrofolate reductase polymorphism and allograft vascular disease after heart transplantation

Pohjala, E.; Nupponen, H.; Lauren, L.; Hannuniemi, R.; Vepsalainen, J.; Kahkonen, J.; Jarvinen, T.; Ahlmark, M., 2001:
Methylenebisphosphonic acid derivatives

Trenti, T.; Sternieri, E.; Franceschetti, F.; Bolelli, G.F., 1999:
Methylenedioxyamphetamine and methylenedioxymethamphetamine External Quality Assessment in urine drug test screening

Riddle, E.L.; Hansen, J.P.; Sandoval, V.; Brown, J.M.; Gibb, J.W.; Hanson, G.R.; Fleckenstein, A.E., 2001:
Methylenedioxymethamphetamine decreases plasmalemmal and vesicular dopamine transport Mechanisms and implications for neurotoxicity

Connor, T.J.; Harkin, A.; Kelly, J.P., 2003:
Methylenedioxymethamphetamine increases LPS-induced IL-10 production via beta-adrenoceptor activation

Lyles, J.; Cadet, J.L.d, 2003:
Methylenedioxymethamphetamine neurotoxicity Cellular and molecular mechanisms

Connor, T.J.; Connelly, D.B.; Kelly, J.P., 2001:
Methylenedioxymethamphetamine suppresses the primary IgG response to an antigenic challenge in rats

Thiriet, N.; Deng, X.; Potapova, O.; Holbrook, N.J.; Cadet, J.L., 2001:
Methylenedioxymethamphetamine-induced apoptosis Role of c-jun

Fidalgo, T.; Matos, V.A.evedo; Pinto, C.S.lva; Martinho, P.; Marques, D.; Marques, A.L.itao; Oliveira, H.; Camacho, M.; Lopes, P.; Goncalves, A.; Tamagnini, G., 2000:
Methylenetetrahidrofolate reductase C677T mutation, homocysteine, folate and fibrinogen in patients with angiographically documented coronary artery disease

Rosenblatt, D.S., 2001:
Methylenetetrahydrofolate reductase

Lacasana, M.; Chen, J.; Galvan, M.; Lopez Carrillo, L., 2003:
Methylenetetrahydrofolate reductase 677 C-T polymorphism and susceptibility to gastric cancer in a high-risk population

Brilakis, E.S.; Berger, P.B.; Ballman, K.V.; Rozen, R., 2003:
Methylenetetrahydrofolate reductase 677C T and methionine synthase reductase 66A G polymorphisms Association with serum homocysteine and angiographic coronary artery disease in the era of flour products fortified with folic acid

Yanamandra, K.; Bocchini, J.A.; Thurmon, T.F., 2003:
Methylenetetrahydrofolate reductase 677CC normal genotype may protect against multiple myeloma

Capra, V.; D.M.rco, P.; Arata, L.; Moroni, A.; Merello, E.; Calevo, M.G.; Cama, A., 2000:
Methylenetetrahydrofolate reductase A1298C polymorphism as a NTD risk factor for the Italian population

Lopez, M.A.; Zuniga, J.; Granados, J.; Mutchinick, O.M., 1999:
Methylenetetrahydrofolate reductase C677T and A1298C gene mutations in an inbred group of Mazateco Indians An ethnic genetic marker for some Amerindian populations?

Donnelly, J.G.; Isotalo, P.A., 2000:
Methylenetetrahydrofolate reductase C677T and A1298C mutations Are they responsible for decreased in utero fetal viability?

Stefanovic, M.; Topic, E.; Simundic, A.M., 2001:
Methylenetetrahydrofolate reductase C677T association with schizophrenia and depression

Mutchinick, O.M.; Lopez, M.A.; Luna, L.; Waxman, J.; Babinsky, V., 1999:
Methylenetetrahydrofolate reductase C677T gene mutation, embryo-maternal genotypes interaction, maternal periconceptional folic acid intake and neural tube defects in the Mexican population

Thurmon, T.; Yanamandra, K.; Ursin, S.A.; Chen, H.; Napper, D.; Dhanireddy, R.; Bocchini, J.A.J.; Rodriguez Paris, J.; Smith, M.; Mills, G.M.; Glass, J., 2003:
Methylenetetrahydrofolate reductase C677T polymorphism and Lung cancer

Matalon, R.K.; Tyring, S.K.; Rady, P.; Hudnall, S.D.vid; Vargas, T.; Nitowsky, H.; Kellner, L.H., 1999:
Methylenetetrahydrofolate reductase High incidence of mutation C677T in Ashkenazi Jewish population

Zeiger, J.S.; Hetmanski, J.B.; Mcintosh, I.; Loffredo, C.; Beaty, T.H., 2001:
Methylenetetrahydrofolate reductase and congenital heart defects Evidence for gene-environment interaction

Rader, J.S.; Zhang, Z.; Nguyen, L.; Borecki, I.; Huettner, P.C.; Watson, E.; Gerhard, D.S., 2002:
Methylenetetrahydrofolate reductase and invasive cervical cancer

Henao, O.L.cia; Piyathilake, C.J.; Waterbor, J.; Johanning, G.; Heimburger, D.; Macaluso, M.; Funkhouser, E.; Partridge, E., 2003:
Methylenetetrahydrofolate reductase and methionine synthase polymorphisms are associated with a decreased risk of cervical dysplasia

Couto, E.; Barini, R.; Nomura, M.; Annichino Bizzacchi, J.M., 2000:
Methylenetetrahydrofolate reductase enzyme and the anticardiolipin antibody gene mutation during pregnancy A case report

Nueckel, H.; Frey, U.H.; Duerig, J.; Duehrsen, U.; Siffert, W., 2004:
Methylenetetrahydrofolate reductase gene 677CT and 1298AC haplotypes New prognostic factors in chronic lymphocytic leukemia

Siemianowicz, K.; Gminski, J.; Garczorz, W.; Slabiak, N.; Syzdol, M.; Polanska, D.; Magiera Molendowska, H.; Machalski, M., 2002:
Methylenetetrahydrofolate reductase gene A1298C polymorphism in patients with lung cancer

Siemianowicz, K.; Gminski, J.; Garczorz, W.; Slabiak, N.; Syzdol, M.; Polanska, D.; Magiera Molendowska, H.; Machalski, M., 2002:
Methylenetetrahydrofolate reductase gene C677T polymorphism in patients with lung cancer

Domagala, T.B.; Czachor, R.; Twardowska, M.; Rybak, M.; Szczeklik, A., 2000:
Methylenetetrahydrofolate reductase gene C677T polymorphism, familial hyperhomocysteinemia and atherothrombosis

Niederland, T.; Gal, V.; Szoke, M.; Jenei, C.; Hollo, Z., 2000:
Methylenetetrahydrofolate reductase gene mutation and hyperinsulinaemia in non-diabetic children

Chen, T.Y.; Chen, J.H.; Tsao, C.J., 2000:
Methylenetetrahydrofolate reductase gene polymorphism and coronary artery disease in Taiwan Chinese

Inamoto, N.; Baba, S.; Katsuya, T.; Mannami, T.; Asai, T.; Ishikawa, K.; Koyama, Y.; Kokubo, Y.; Higaki, J.; Ogata, J., 2001:
Methylenetetrahydrofolate reductase gene polymorphism associates with carotid atherosclerosis in a Japanese population The Suita study

Tavakkoly Bazzaz, J.; Shojapoor, M.; Nazem, H.; Amiri, P.; Fakhrzadeh, H.; Heshmat, R.; Parvizi, M.; Hasani Ranjbar, S.; Amoli, M.M., 2010:
Methylenetetrahydrofolate reductase gene polymorphism in diabetes and obesity

Scaglione, L.; Gambino, R.; Gay, M.; Lillaz, E.; Cassader, M.; Pagano, G.; Cavallo Perin, P., 1999:
Methylenetetrahydrofolate reductase gene polymorphism is not associated to diabetic nephropathy in type 2 diabetes

Koch, W.; Latz, W.; Eichinger, M.; Lengnick, H.; Burghartz, M.; Koelling, K.; Schoemig, A.; Kastrati, A., 2003:
Methylenetetrahydrofolate reductase gene polymorphisms and risk of restenosis after coronary artery stenting

Neri, J.I.C.F.; Arruda, V.R.; Cavalcanti, D.P., 2001:
Methylenetetrahydrofolate reductase genetic polymorphism; a possible restrictive relationship between C677T mutation with lower neural tube defects

Welsch, M.A.; Allen, J.D.; Tulley, R.; Wilson, J.; Smith, S.; Lefevre, M., 2003:
Methylenetetrahydrofolate reductase genotype expression and arterial reactivity

Kluijtmans, L.A.J.; Whitehead, A.S., 1999:
Methylenetetrahydrofolate reductase genotypes and predisposition to atherothrombotic disease Evidence that the wild type 677 CC genotype is protective

Andreassi, M.G.azia; Botto, N.; Manfredi, S.; Colombo, M.G.ovanna; Masetti, S.; Antonioli, E.; Trianni, G.; Palmieri, C.; Biagini, A., 2001 :
Methylenetetrahydrofolate reductase genotypes as a risk factor for major adverse cardiac events after coronary revascularization

Wilson, V.L.; Yin, X.; James, S.J.ll; Swenson, D.H., 2000:
Methylenetetrahydrofolate reductase genotyping at 13 different base sites

Wilsky, C.E.; Kauwell, G.P.A.; Cerda, J.; Herrlinger Garcia, K.; Hutson, A.; Boddie, A.; Bailey, L.B., 1999:
Methylenetetrahydrofolate reductase mutation negatively influences plasma homocysteine response to marginal folate intake in elderly women

Bitzer, M.; Schulz, W.A.; Gabbert, H.E.; Sarbia, M., 2002:
Methylenetetrahydrofolate reductase polymorphism and susceptibility to esophageal carcinoma

Markey, J.C.; Rudnik, O.; Nowak, R.; Decker, S.; James, S.J.ll; Stanton, D.; Pogribna, M.; Wilson, V.L.; Swenson, D.H., 2002:
Methylenetetrahydrofolate reductase polymorphism in control, alzheimers disease and down syndrome populations

Dayton, J.P.; Henkenius, A.L.; He, P.; Walvis, K.; Van Doorn, J.; Wang, H.; Baker, S.T.; Wakamatsu, P.; Seeger, R.C.; Van Tornout, J.M., 2000:
Methylenetetrahydrofolate reductase polymorphism is a risk factor for developing neuroblastoma

Shelnutt, K.P.gan; Kauwell, G.P.A.; Gregory, J.F.I.i; Maneval, D.; Theriaque, D.W.; Browdy, A.L.; Bailey, L.B., 2003:
Methylenetetrahydrofolate reductase polymorphism negatively affects folate status response to controlled folate intake in young women

Mcglynn, K.A.; Wang, L.; Patrick Acevedo, N.Y.; Strachan, S.D.; Kruger, W.D., 2000:
Methylenetetrahydrofolate reductase, methionine synthase, folate, alcohol and breast cancer

Akar, N.; Akar, E., 2000:
Methylenetetrahydrofolate-dehydrogenase 1958 G-A polymorphism in Turkish patients with venous thromboembolism

Murata, M.; Yokota, A.; Horii, K.; Tsubouchhi, N.; Takeshita, E.; Yamamoto, M.; Meguro, S.; Takei, N.; Saruta, T.; Takei, I.; Watanabe, K., 1999:
Methylenetetrahydrolate reductase genotype is associated with plasm homocysteine levels and ankle pressure index in type 2 diabetes mellitus

Maroof, S.; Usmani, H.; U.H.da, W.; Jafri, F.; Qadir, A., 2003:
Methylergonovine Maleate Relieves Postdural Puncture Headache in Obstetrical Patients

Hughes, K.; Roberts, D.; Kovarik, S., 2002:
Methylergonovine mix-up in the delivery room

Yourick, J.J.; Bronaugh, R.L., 2003:
Methyleugenol skin absorption in human and fuzzy rat skin

Lodge Ivey, S.L.; Petersen, M.K.; May, T., 2002:
Methylglyoxal A novel tool to assess nitrogen status of the rumen

Ward, R.A.; Mcleish, K.R., 2002:
Methylglyoxal A stimulus to oxygen radical production in chronic renal failure?

Mowri, H.O.i; Keaney, J.F., 2000:
Methylglyoxal and glyoxal enhance LDL oxidation through modification of apo B arginyl residues

Mowri, H.O.i; Keaney, J.F.Jr, 2000:
Methylglyoxal and glyoxal enhance metal ion-dependent LDL oxidation

Wu, L.; Juurlink, B.H.J., 2002:
Methylglyoxal and hypertensive vascular damage

Ahmed, N.; Portero, M.; Haik, G.J.; Thornalley, P., 2003:
Methylglyoxal and methylglyoxal-derived advanced glycation end-products of hemoglobin in type 1 diabetes with and without retinopathy

Godbout, J.P.ilip; Pesavento, J.; Freund, G.G., 2001:
Methylglyoxal enhances cisplatin cytotoxicity through a protein kinase C delta-dependent pathway

Karadi, Z.; Lukats, B.; Wittmann, I.; Degrell, P.; Kocsis, B.; Nagy, J., 2002:
Methylglyoxal induced dysfunctions of the ventromedial hypothalamic nucleus in the rat

Liu, B.F.n; Miyata, S.; Miyazaki, H.; Fukunaga, M.; Hamada, Y.; Ueyama, S.; Muramoto, O.; Jiang, Q.Y.n; Kusunoki, H.; Uriuhara, A.; Hirota, Y.; Kasuga, M., 2002:
Methylglyoxal induces apoptosis in rat mesangial cells

D.L.reto, S.; Caracciolo, V.; Colafarina, S.; Gasbarri, A.; Amicarelli, F., 2002:
Methylglyoxal induces oxidative stress and ngf increase in cultured hippocampal neurons

Thornalley, P.J.; Wentzel, P.; Karachalias, N.; Eriksson, U.J., 2001:
Methylglyoxal is less teratogenic than 3-dexoyglucosone due to rapid metabolism in embryos exposed to high glucose concentration in vitro

Aguilera, J.; Preito, J.A.tonio, 2003:
Methylglyoxal levels An internal signal for the genetic response?

Mazak, I.; Wittmann, I.; Wagner, Z.; Wagner, L.; Vas, T.; Nagy, J., 2000:
Methylglyoxal produced in non-enzymatic glycation evokes oxidative stress and calcium accumulation in human red blood cells

Liu, B.F.n; Miyata, S.; Miyazaki, H.; Fukunaga, M.; Hamada, Y.; Ueyama, S.; Muramoto, O.; Kasuga, M., 2001:
Methylglyoxal, a highly reactive dicarbonyl compound, induces apoptosis in rat mesangial cells

Takagi, M.; Kai, Y.; Imanaka, T., 2001:
Methylguanine methyltransferase from Thermococcus kodakaraensis KOD1

Neff, T.; Peterson, L.J.; Thompson, J.; Von Kalle, C.; Kiem, H.P.ter, 2003:
Methylguanine-methyltransferase allows for efficient long term in vivo selection and marrow protection with O6BG and BCNU or temozolomide in a large animal model

Bru Magniez, N.; Guillon, X.; Breton, P.; Couvreur, P.; Lescure, F.CedillaOis; Roques Carmes, C.; Riess, G., 2002:
Methylidene malonate nanoparticles

Poppe, L., 2001:
Methylidene-imidazolone: a novel electrophile for substrate activation

Checinska, L.; Kudzin, Z.H.; Malecka, M.; Nazarski, R.B.; Okruszek, A., 2003:
Methylidenetriphenylphosphorane The double P+-stabilised carbanion A crystallographic, computational and solution NMR comparative study on the ylidic bonding

Lind, R.J.; Hardick, D.J.; Blagbrough, I.S.; Potter, B.V.L.; Wolstenholme, A.J.; Davies, A.R.L.; Clough, M.S.; Earley, F.G.P.; Reynolds, S.E.; Wonnacott, S., 2001:
Methyllycaconitine A high affinity radioligand that labels invertebrate nicotinic acetylcholine receptors

Lalo, U.; Pankratov, Y.; Krishtal, O.; North, R.Alan., 2004:
Methyllycaconitine, alpha-bungarotoxin and (+)-tubocurarine block fast ATP-gated currents in rat dorsal root ganglion cells

Kimura, I.; Dezaki, K., 1999:
Methyllycaconitine-, alpha-bungarotoxin-sensitive neuronal nicotinic receptor operates slow calcium signal in skeletal muscle end plate

Hoerster, F.; Okun, J.G.; Mayatepek, E.; Hoffmann, G.F.; Koelker, S., 2001:
Methylmalonate-mediated complex II inhibition Effect or artefact?

Schwab, M.; Koelker, S.; Sauer, S.; Hinz, A.; Wolf, N.; Hoffmann, G.; Smeitink, J.; Okun, J., 2003 :
Methylmalonic acid Biochemical hallmark but no inhibitor of mitochondrial respiratory chain

Aguirre, C.; Barreiro, G., 2002:
Methylmalonic acid and clinical practice

Wajner, M.; Pettenuzzo, L.F.; Schuck, P.F.; Wannmacher, C.M.D.; Wyse, A.T.S.; Dutra Filho, C.S., 2003:
Methylmalonic acid induces oxidative stress in rat striatum

Brusque, A.M.; Rosa, R.B.; Schuck, P.; Dalcin, K.; Wannmacher, C.M.D.; Dutra Filho, C.S.; Wyse, A.T.S.; Briones, P.; Wajner, M., 2001:
Methylmalonic acid inhibits activities of the respiratory chain complexes in rat brain

Choy, Y.S.; Pertiwi, A.K.D.; Zabedah, Y.; Noor, F.I., 2002:
Methylmalonic acidemia Associated birth defects and atypical presentations

Winter, S.C., 2000:
Methylmalonic acidemia Improved renal function and reversal of pancreatitis associated with IV carnitine therapy

Belson, A.; Enns, G.; Berquist, W.E.; Sarwal, M., 2000:
Methylmalonic acidemia nephropathy Management of a rare disorder

Bain, M.D.; Till, J.; Jones, M.G.; Besley, G.T.N.; Lee, P.; Oliveira, D.; Chalmers, R.A., 2006:
Methylmalonic aciduria: follow-up and enzymology on the original case after 36 years

Bain, M.D.; Jones, M.G.; Oliviera, D.; Chalmers, R.A., 2001:
Methylmalonic aciduria Functional adult outcome is not dependent upon mutation but on presentation and treatment

Galvin Parton, P.A.; Mandal, K.; Parker, R.; Neil, J.; Prakash, D., 2002:
Methylmalonic aciduria revisited Under recognized symptoms and indications for testing

Nikkel, S.M.; Mhanni, A.; Dilling, L.; Seargeant, L.; Stobart, K.; Rosenblatt, D.; Gorlin, J.B.; Korson, M.S.; Greenberg, C.R.; Prasad, C., 2000:
Methylmalonic aciduria, hyperhomocysteinemia, hematologic and/or neurologic abnormalities in 3 infants born to mothers with asymptomatic B12 deficiency

Farland, William H., 2001:
Methylmercury Assessing and managing risk to vulnerable populations

Ramos, C.; Estevez, S.; Giraldo, E., 2002:
Methylmercury analysis in environmental samples from La Mojana region in Colombia

Bellinger, David, 2001:
Methylmercury and PCB studies Stand back and look at the whole picture

Desrosiers, M.; Planas, D.; Mucci, A., 2002:
Methylmercury and THg accumulation of littoral communities in lakes of pre- and post-harvest watersheds

Ruelas Inzunza, J.R.; Horvat, M.; Perez Cortes, H.; Paez Osuna, F., 2003:
Methylmercury and total mercury distribution in tissues of gray whales and spinner dolphins stranded along the lower Gulf of California, Mexico

Parran, D.K.; White, L.D.; Barone, S., J., 2001:
Methylmercury but not mercuric chloride induces apoptotic cell death in PC12 cells

Limke, T.L.; Bearss, J.J.; Marty, M.S.; Atchison, W.D., 2001:
Methylmercury causes intracellular calcium release by interaction with muscarinic receptors

Edwards, J.R.; Atchison, W.D., 2001:
Methylmercury causes prominent elevations of both calcium and non-calcium divalent cations in Purkinje cells in culture

Lewandowski, T.A.; Hong, S.; Pingree, S.; Pierce, C.H.; Ponce, R.A.; Faustman, E.M., 1999:
Methylmercury distribution in pregnant rats and their fetuses during early organogenesis

Trasande, L.; Cortes, J.E.; Landrigan, P.J.; Abercrombie, M.I.; Bopp, R.F.; Cifuentes, E., 2010:
Methylmercury exposure in a subsistence fishing community in Lake Chapala, Mexico: an ecological approach

Lundback, S.S.; Musetti, V.M.; Marty, M.S.; Atchison, W.D., 2002:
Methylmercury induced alterations in calcium homeostasis in rat cerebellar type ii astrocytes

Yuan, Y.; Atchison, W.D., 2003:
Methylmercury induces an unidentified transient giant slow inward current in Purkinje cells in rat cerebellar slices

Gilmour, C.C.; Heyes, A.; Mason, R.; Krabbenhoft, D., 2003:
Methylmercury production in response to a whole-watershed sable Hg lotope spike

Jeremiason, J.D.; Swain, E.B.; Brezonik, P.L.; Hines, N.A.; Nater, E.; Cotner, J.; Johnson, B.; Engstrom, D.R.; Almendinger, J., 2002:
Methylmercury sources to lakes in forested watersheds Has enhanced methylation increased mercury levels in fish relative to atmospheric deposition?

Vettori, M.V.; Alinovi, R.; Gatti, R.; Belletti, S.; Orlandini, G.; Mutti, A., 2000:
Methylmercury toxicity to catecholaminergic and glial cells

O'hara, M.F.; Knudsen, T.B., 2000:
Methylmercury transiently alters mitochondrial gene expression in the embryo Evidence for disruption of the cellular heme pathway

Blanchfield, P.J.; Podemski, C.L.; Paterson, M.J.; Rudd, J.W.M.; Kelly, C.A.; Hintelmann, H.H.; Gilmour, C.C.; Harris, R.C., 2002:
Methylmercury uptake by biota in an Oligotrophic lake Insights from stable mercury isotopes

Peng,; Yao, A.Z.; Atchison, W.D., 2003:
Methylmercury-induced block of voltage-gated Ca2+ channels in acutely isolated cerebellar Purkinje neurons of rats

Sarafian, T.A., 1999:
Methylmercury-induced generation of free radicals: biological implications

Brown, D.L.; Hunter, A.M.; Villenueve, T.; Currie, K.; Campos, E., 2000:
Methylmercury-induced microtubule dissassembly and the induction of apoptosis in P19 embryonal carcinoma cells

Allen, J.W.; Aschner, M., 2001:
Methylmercury-mediated inhibition of cystine and glutamate uptake in primary cortical astrocyte cultures

Moss, J.; Ho, W.Z.e; Guo, C.J.ang; Yuan, C.S.; Douglas, S.D., 2003:
Methylnaltrexone Prevents Morphine-Induced CCR5 Receptor Expression

Aung, H.H.; Mehendale, S.R.; Xie, J-Tian.; Moss, J.; Yuan, C-Su., 2004:
Methylnaltrexone prevents morphine-induced kaolin intake in the rat

Yuan, C.S.; Doshan, H.; O'connor, M.F.; Maleckar, S.A.; Israel, R.J.; Moss, J., 2003:
Methylnaltrexone reduces oral cecal transit time in humans

Yuan, C.S.; Foss, J.F.; O'connor, M.; Osinski, J.; Wu, J.A.; Sellers, D.; Lowell, T.; Moss, J.; Roizen, M.F., 1999:
Methylnaltrexone reverses chronic opioid constipation A double-blind, randomized, placebo-controlled trial

Roje, S.; Hanson, A.D.; Raymond, R., 1999:
Methylneogenesis in plants Identification and characterization of cDNAs encoding methylenetetrahydrofolate reductase

Zhang, X.; Sobol, R.; Wilson, S.; Shane, B., 2000:
Methylnitrosourea , a non-hepatocarcinogenic agent, causes mutations in the liver following cell proliferation induced by a partial hepatectomy

Gomez, G.; Richie, E.R., 1999:
Methylnitrosourea induces CD4+- 8+ thymocytes and thymic lymphomas in RAG-/-

Dunfield, P.F.; Dedysh, S.N., 2003:
Methylocella silvestris is a facultative methanotroph

Bishop, Y.M.; Barton, L.L.; Johnson, G.V., 2002:
Methylotrophic bacteria in the phyllosphere of plants Possible roles in nutrient translocation

Fujimura, S.; Nakagawa, T.; Miyaji, T.; Yurimoto, H.; Sakai, Y.; Kato, N.; Tomizuka, N., 2003:
Methylotrophic pathway participates in pectin utilization by Candida boidinii

Nourizad, N.; Ehn, M.; Gharizadeh, B.; Hober, S.; Nyren, P., 2003:
Methylotrophic yeast Pichia pastoris as a host for production of ATP-diphosphohydrolase from potato tubers

Macy, E.; Schatz, M.; Zeiger, R.S., 2002:
Methylparaben immediate hypersensitivity is a rare cause of false positive local anesthetic provocative dose testing

Anderson, C.M.; Silveri, M.M.; Teicher, M.H.; Lukas, S.E.; Renshaw, P.F.; Kaufman, M.J., 2003:
Methylphenidate - induced blood flow in human subjects correlates with T2 - relaxation time in the cerebellar vermis lobule VIIB at baseline and subjective Xdesire for drug X

Viggiano, D.; Vallone, D.; Ruocco, L.A.; Sadile, A.G., 2003:
Methylphenidate - induced neuro - behavioral changes functional neuroimaging analysis in an animal model of ADHD

Leonard, B.E.; McCartan, D.; White, J.; King, D.J., 2004:
Methylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effects

Klein Schwartz, W.; Mcgrath, J., 2001:
Methylphenidate abuse in pre-teens and adolescents

Vongher, J.M.; Durgerian, S.; Fischer, M.; Salmeron, B.J.; Stein, E.A.; Risinger, R.C.; Harrington, D.L.; Rao, S.M., 2001:
Methylphenidate alters patterns of neural activation during timing reproduction An fMRI study

Prieto Gomez, B.; Herrera Ruiz, M.; Vazquez Alvarez, A.; Dafny, N.; Reyes Vazquez, C., 2002:
Methylphenidate and amphetamine single administration effects on glutamatergic ventral tegmental area synaptic currents

Panksepp, J.; Burgdorf, J.; Turner, C.; Gordon, N., 2001:
Methylphenidate and rat play Evidence for sensitization of ultrasonic vocalizations and implications for ADHD

Martin, C.A.; Kelly, T.H.; Guenthner, G.; Lane, S.D.; Bingcang, C., 2002:
Methylphenidate effects on task performance in ADHD adolescents

Mehta, M.A.; Goodyer, I.M.; Sahakian, B.J., 2000:
Methylphenidate enhances performance on tests of working memory and attentional set-shifting in children with attention deficit/hyperactivity disorder

Walker, L.W.; Waterhouse, B.D., 2003:
Methylphenidate exerts differential effects on strong vs weak responses of sensory cortical neurons to synaptic inputs in anesthetized rats

Hopkins, U.; Klein Schwartz, W.; Anderson, B.; Sailley, A., 1999:
Methylphenidate exposures 5 years of poison center experience

Keating, G.M.; Mcclellan, K.; Jarvis, B., 2001:
Methylphenidate formulation

Brake, W.G.; Giannotti, K.A., 2002:
Methylphenidate has reduced locomotor stimulant effects on juvenile rats asphyxiated at birth

Ueno, K.I.hi; Togashi, H.; Mori, K.; Matsumoto, M.; Ohashi, S.; Hoshino, A.; Fujita, T.; Saito, H.; Minami, M.; Yoshioka, M., 2001:
Methylphenidate improves short-term memory deficit and hyperactivity in stroke-prone spontaneously hypertensive rats

Sandoval, V.; Ugarte, Y.V.; Gibb, J.W.; Hanson, G.R.; Fleckenstein, A.E., 2001:
Methylphenidate increases vesicular dopamine uptake

Mozley, P.D.; Mozley, L.M.H.; Acton, P.D.; Plossl, K.; Gur, R.C.; Kulinski, J.A.; Keeney, C.F.nkelman; Kung, H.F., 2001:
Methylphenidate induced changes in behavior are related to the specific uptake of 99mTcTRODAT-1

Lee, J.S.; Kim, B.N.; Lee, D.S.; Kim, Y.K.; Chung, J.K.; Cho, S.C.; Lee, M.C., 2002:
Methylphenidate induced changes in regional cerebral blood flow in children with attention deficit hyperactivity disorder

Aston, J.C.; Kosar, F.; Rawji, F.; Elliott, J.M.; Zetterstrom, T.S.C., 2002:
Methylphenidate induces ARC mRNA expression differentially in adult and juvenile rat brain

Acheson, A.W.; Thompson, A.C.; Kristal, M.B.; Baizer, J.S., 2001:
Methylphenidate induces c-fos expression in juvenile rats

Bailey, B.; Letarte, A.; Abran, M.C., 2003:
Methylphenidate ingestion in pre-school children A case series

Bettman, M.J.; Percel, P.J.; Hensley, D.L.; Vishnupad, K.S.; Venkatesh, G.M., 2002:
Methylphenidate modified release formulations

Klorman, R.; Brumaghim, J.T.; Borgstedt, A.D., 2000:
Methylphenidate normalizes effects of memory load and response selection on ADHD adolescents

Sandoval, V.; Hanson, G.R.; Fleckenstein, A.E., 2002:
Methylphenidate prevents methamphetamine induced dopaminergic deficits

Kidani, Yuri; Ishimatsu, Masaru; Akasu, Takashi, 2000:
Methylphenidate produces a hyperpolarizing response via alpha2-adrenoceptors in neurons of the rat locus coeruleus

Sandoval, V.; Hanson, G.R.; Fleckenstein, A.E., 2002:
Methylphenidate redistributes vesicular monoamine transporter-2 immunoreactivity Role of dopamine receptors

Laqueille, X.; Dervaux, A.; E.O.ari, F.; Kanit, M.; Bayle, F.J., 2003:
Methylphenidate replacement A long-term treatment of non-comorbid amphetamine abusers?

Dafny, N.; Yang, P.; Amini, B.; Swann, A., 2002:
Methylphenidate treatment in adolescents elicits sensitization in adulthood

Bridgeford, D.; Arciniegas, D.B.; Batkis, M.; Martin, B.; Beresford, T.P., 2000:
Methylphenidate treatment of psychiatric symptoms from Central Pontine Myelinolysis

Crutchley, A.; Temlett, J.A., 1999:
Methylphenidate use and abuse

Rosa Neto, P.; Lou, H.; Cumming, P.; Pryds, O.; Gjedde, A., 2002:
Methylphenidate-evoked potentiation of extracellular dopamine in the brain of adolescents with premature birth: correlation with attentional deficit

Hyman, S.E., 2003:
Methylphenidate-induced plasticity: what should we be looking for?

Desmarais, S.; Friesen, R.W.; Zamboni, R.; Ramachandran, C., 1999:
Methylphenylalanine-containing peptide inhibitors of protein tyrosine phosphatases

Mannaioni, G.; Peavy, R.D.; Gordon, F.J.; Conn, P.J., 1999:
Methylphenylethynylpyridine selectively antagonizes mGluR5-mediated excitatory response in CA1 pyramidal neurons and in cultured astrocytes

Amin, K.; Elebring, T.; Guzzo, P.; Olsson, T.; Swanson, M.; Von Unge, S., 2003:
Methylphosphinic acids

Kosley, R.W.Jr; Spahl, B.; Effland, R.C., 2002:

Fu, E.S.; Saporta, S.; Kim, J.J., 2002:
Methylprednisolone Inhibits Cytokine Production in the Spinal Cord Following Compression Injury in Rats

Takami, T.; Oudega, M.; Marcillo, A.E.; Bethea, J.R.; Bunge, M.B., 2000:
Methylprednisolone alone and in combination with human IL-10 reduces gray matter but not white matter loss in the contused adult Fischer rat thoracic spinal cord

Quandt, F.N.; Katsamakis, G.; Stefoski, D.; Hassen, E.; Sagett, S., 1999:
Methylprednisolone alters the balance of Th1-Th2 cytokine mRNA in blood mononuclear cells from Multiple Sclerosis patients

Ray, S.K.; Wilford, G.G.; Banik, N.L., 2004:
Methylprednisolone and indomethacin inhibit oxidative stress induced apoptosis in rat C6 glioblastoma cells

Bracken, M.B., 2000:
Methylprednisolone and spinal cord injury

D.S.heerder, I.; Huan, Y.; Ping, Q.B.i; Wang, L.; Vermeire, I.; Verbeken, E.; Schacht, E., 2000:
Methylprednisolone coated stents decrease neointimal hyperplasia in a porcine coronary model

Chauvaud, D.; E.A.uni, A.; Behar Cohen, F., 1999:
Methylprednisolone concentrations in the vitreous and serum after pulstherapy

Diem, R.; Hobom, M.; Maier, K.; Weissert, R.; Storch, M.K.; Meyer, R.; Baehr, M., 2003:
Methylprednisolone increases neuronal apoptosis during chronic inflammatory disease of the CNS by inhibition of an endogenous neuroprotective pathway

Yates, C.R.; Vysokanov, A.; Mukherjee, A.; Ludden, T.; Tolley, E.; Meduri, U.; Dalton, J.T., 2000:
Methylprednisolone population kinetics in patients with acute respiratory distress syndrome

Chen, S.; Chen, H.; Lee, J.; Hsu, C.; Xu, J., 2003:
Methylprednisolone protects AMPA - induced apoptosis in oligodendrocytes

Lee, Y.K.; Kim, G.H.; Chun, R.W.n; Oh,; Kim, S.K.un; Yoon, J.W.o; Suh, C.W.n; Park,; Noh, J.W.o, 2003:
Methylprednisolone pulse therapy in adult-onset minimal change nephrotic syndrome

Jardim, M.R.; Nascimento, O.J.M.; Nery, J.A.C.; Sarno, E.N., 2001:
Methylprednisolone pulse therapy in leprosy neuropathy

Gold, R.; Schmidt, J.; Zettl, U.K.; Hartung, H.P.ter; Toyka, K.V., 1999:
Methylprednisolone pulse therapy of experimental autoimmune encephalomyelitis Direct correlation of T cell apoptosis In situ and MP concentration in spinal cord

Solberg, Y.; Dubinski, G.; Tchirkov, M.; Belkin, M.; Rosner, M., 1999:
Methylprednisolone therapy for retinal laser injury

Omay, S.B.; Tobu, M.; Saydam, G.; Uzunoglu, S.; Selvi, N.; Aydin, H.H.; Uslu, R.; Yuksel, S.; Buyukkececi, F., 1999:
Methylprednisolone-induced differentiation of myeloid leukemia cells is enhanced by calcineurin inhibitors

Buntinas, L.; Krippeit, P.; Drews, G.; Eikholt, C.; Horn, T.F.W.; Siemen, D., 2002:
Methylpyruvate decreases open probability of a 55 pS-channel in the inner mitochondrial membrane

Sinha, R.; Ganther, H.E.; Medina, D., 1999:
Methylseleninic acid, a novel selenium compound inhibits mouse mammary epithelial tumor cells in vitro

Lu, J.; Jiang, C.; Ganther, H., 2001:
Methylselenium specific inhibition of cancer epithelial expression of vascular endothelial growth factor

Lu, J.; Jiang, C.; Wang, Z.; Ganther, H., 2000:
Methylselenol as a proximal inhibitory selenium metabolite for matrix metalloproteinases and angiogenesis

Gopalakrishna, R.; Gundimeda, U., 2003:
Methylselenol, the active metabolite of selenium, selectively inhibits protein kinase C in precancer cells at the promotional stage of carcinogenesis

Jiang, C.; Wang, Z.; Ganther, H.; Lu, J., 2001:
Methylselenol-induced cancer cell anoikis is executed through a caspase-dependent mechanism

Letcher, R.J.; Norstrom, R.J.; Muir, D.C.G.; Sandau, C.D.; Koczanski, K.; Michaud, R.; D.G.ise, S.; Beland, P., 2000:
Methylsulfone polychlorinated biphenyl and 2,2-bis -1,1-dichloroethylene metabolites in beluga whale from the St Lawrence River estuary and western Hudson Bay, Canada

Carlsson, C.; Fredriksson, A.; Brandt, I., 2002:
Methylsulphonyl-2,6-dichlorobenzene produces olfactory mucosal metaplasia accompanied by hyperactivity and acquisition deficits in male and female rats

Erhorn, S.; Lang, D.; Doshi, S.; Lewis, M.J., 2002:
Methyltetrahydrofolate and tetrahydrobiopterin inhibit methionine-induced endothelial dysfunction in rabbit aortic rings An antioxidant-independent effect?

Hellerbrand, C.; Schuierer, M.; Muhlbauer, M.; Wallner, S.; Behrmann, I.; Bataille, F.; Schoelmerich, J.; Bosserhoff, A.K., 2004:
Methylthioadenosin phosphorylase expression is frequently lost in hepatocellular carcinoma

Efferth, T.; Miyachi, H.; Drexler, H.G.; Gebhart, E., 2002:
Methylthioadenosine phosphorylase as target for chemoselective treatment of tumors with 9p21 deletion

Li, W.W.i; Cole, P.; Martin, D.; Banerjee, D.; Bertino, J.R., 2000:
Methylthioadenosine phosphorylase status determines sensitivity to L-alanosine in human soft tissue sarcoma cell lines and is enhanced by 6-methylmercapotpurine riboside

Kladde, M.P.; Simpson, R.T.; Xu, M., 2002:
Methyltransferase gene and enzyme

Rounds, S.; Johnson, T.; Harrington, E.O.; Bellas, R.E.; Newton, J., 2002:
Methyltransferase inhibition causes endothelial apoptosis by inhibition of PI3-kinase

Harrington, E.O.; Newton, J.L.; Rounds, S., 2002:
Methyltransferase inhibition decreases endothelial cell migration and monolayer permeability

Yu, H.; Jiao, Y., 2000:
Methyltrioxorhenium catalyzed oxidation of purines and deazapurines into their N-oxides

Stadler, R.H.,.; Turesky, R.J., 1999:
Methyluric acids Chemical markers of oxidation on coffee, tea and cocoa

Al-Obaidi,H.; Afzal,M., 2010:
Methylxanthine content in hot drinks consumed in the State of Kuwait

Schmidt, B., 1999:
Methylxanthine therapy in premature infants: sound practice, disaster, or fruitless byway?

Davis, P.G.; Doyle, L.W.; Rickards, A.L.; Kelly, E.A.; Ford, G.W.; Davis, N.M.; Callanan, C., 1999:
Methylxanthines and sensorineural outcome at 14 years in children less than 1501g birthweight

Kulkarni, C., 2002:
Methylxanthines as tools-from therapeutics to experimental An overview

Rusche, J.R.; Zhang, J., 2002:
Methylxanthines in the diagnosis and treatment of autistic disorder

Martin, R.J.; Bai, G.; Clark, C.L.; Robertson, A.P., 2003:
Methyridine -pyridine and levamisole activate different ACh receptor subtypes in nematode parasites A new lead for levamisole-resistance

Zhang, X.J.; Wolfe, R.R., 1999:
Methysergide administration reduces non-nutritive blood flow in the early scalded skin

Noubhani, A.; Cappetta, H., 2002:
Metlaouia Noubhani and Cappetta, 1997 preoccupied by Metlaouia Dumont, 1928

Saito, M.; Shibata, O.; Yamaguchi, M.; Niwa, M.; Sumikawa, K., 2003:
Metoclopramide Alters Binding Affinity of Muscarinic M3 Receptor of Rat Trachea

Harrison, A.X.; Ramsey, K.W.; Moretti, E.W.; Radu Radulescu, L.; Somma, J., 2002:
Metoclopramide Is a Potential Factor Related to an Unusually High Dropout Rate in a Complex Study Protocol in Healthy Human Volunteers

Steinberg, David, 2003:
Metoclopramide and Succinylcholine-Mivacurium Sequence

Fox, A.W., 2004:
Metoclopramide and sumatriptan

Miozzari, A.; Rajeswaran, R.; Zimmermann, G.; Krenz, S.; Zullino, D.F., 2003:
Metoclopramide and ondansetron prn during multidrug withdrawal

Shaffer, D.; Butterfield, M., 2002:
Metoclopramide and tardive dyskinesia A review of the FDA adverse event reporting system

Shibata, O.; Saito, M.; Makita, T.; Sumikawa, K., 2002:
Metoclopramide attenuates carbachol-induced contractile and PI responses of rat trachea

Hansen, W.; Hunter, S.; Mcandrew, S.; Harris, K.; Zimmerman, B., 2001:
Metoclopramide concentration in breast milk of women delivering between 23-34 weeks gestation

Henzi, I.; Tramer, M.R., 2003:
Metoclopramide for the control of postoperative nausea and vomiting

Thyes, C.; Kuehn, F.; Ewald, V.; Petroianu, G., 2002:
Metoclopramide protects cholinesterase from inhibition by paraoxon

Khan, H.A.; A.M.utaery, K.; A.D.eb, S.; Tariq, M., 2003:
Metoclopramide, a dopamine receptor antagonist, attenuates iminodipropionitrile-induced neurobehavioral toxicity in rats

Cezard, C.; Nisse, P.; Quaranta, S.; Peucelle, D.; Mathieu Nolf, M., 2003:
Metoclopramide-induced acute dystonia in children

Karadsheh, N.S.; Shaker, Q.; Ratroat, B., 2001:
Metoclopramide-induced methemoglobinemia in a patient with co-existing deficiency of glucose-6-phosphate dehydrogenase and NADH-cytochrome b5 reductase: failure of methylene blue treatment

Lyday, W.D.; DiBaise, J.K., 2002:
Metoclopramide-stimulated gastric emptying scintigraphy: does it predict symptom response to prokinetic therapy in chronic gastroparesis?

Perovic, S.V.; Djordjevic, M.L., 2001:
Metoidioplasty A variant of phalloplasty in female transsexuals

Pridjian, G.; Ianosi Irimie, M.; Vu, H.; Pridjian, C.; Durst, J.; Whitbred, J.; Puschett, J., 2003:
Metolazone ameliorates the hypertension and fetal growth restriction in a rat model of preeclampsia

Gabrielli, M.; Gasbarrini, A.; Santoliquido, A.; Flore, R.; Gaetani, E.; Flex, A.; Pola, P., 2001:
Metolazone-induced cholestatic liver disease

Schwendinger, P.J.; Pape, T., 2000:
Metopia sinensis , an unusual predator of Liphistius in northern Thailand

Lattin, J.D.; Wetherill, K., 2002:
Metopoplax ditomoides , a species of Oxycarenidae new to North America

Sulej, Tomasz, 2001:
Metoposaur-dominated fossil assemblages of the late Triassic

Prakash, A.; Markham, A., 2000:
Metoprolol: a review of its use in chronic heart failure

Ghali, J.K.; Pina, I.L.; Gottlieb, S.S.; Deedwania, P.C.; Wikstrand, J.C., 2001:
Metoprolol CR/XL in female patients with heart failure Analysis of the experience in MERIT-HF

Jánosi, Aás.; Ghali, J.K.; Herlitz, J.; Czuriga, Ián.; Klibaner, M.; Wikstrand, J.; Hjalmarson, A., 2003:
Metoprolol CR/XL in postmyocardial infarction patients with chronic heart failure: experiences from MERIT-HF

Brunner L.R.cca, H.P.; Meler, A.; Scharf, C.; Schindler, R.; Oechslin, E.; Fink, B.; Armbrecht, J.; Lutiger, B.; Bassenge, E.; Kiowski, W., 2001:
Metoprolol and carvedilol similarly reduce nitrate tolerance in healthy men

Ebbehoj, E.; Poulsen, P.L.; Hansen, K.W.; Molgaard, H.; Mogensen, C.E., 2000:
Metoprolol improves heart rate variability in ACE-inhibitor treated type 1 diabetic patients with abnormal albuminuria

Hall, C.; Rouleau, J.L.; White, M.; Mckelvie, R.; Maggioni, A.; Latini, R.; Yusuf, S., 1999:
Metoprolol in chronic heart failure Natriuretic peptides involved in mechanism of action?

Kirchheiner, J.; Meisel, C.; Heesch, C.; Bauer, S.; Keulen, T.; Henckel, H.; Roots, I.; Brockmoeller, J., 2004:
Metoprolol pharmacokinetics and pharmacodynamics in carriers of CYP2D6 genotypes pre-dicting ultra-rapid metabolism

Crystal, E.; Connolly, S.J.; Thorpe, K.; Cybulsky, I.; Lamy, A.; Roberts, R.; Gent, M., 2001:
Metoprolol prophylaxis against post-operative atrial fibrillation increases length of hospital stay in patients not on pre-operative beta-blockers The beta-blocker length of stay Trial

Rundqvist, B.; Bergmann-Sverrisdottir, Y.; Andersson, B.; Elam, M.; Eisenhofer, G.; Waagstein, F.; Friberg, P., 2001 :
Metoprolol reduces sympathetic nerve hyperactivity in patients with heart failure

Hildemann, S.K.; Fischer, H.; Pittrow, D.; Bohlscheid, V., 2002:
Metoprolol succinate SR plus hydrochlorothiazide comp in patients with essential hypertension in general practice A prospective, observational trial in 14 964 patients

Rundqvist, B.; Friberg, P.; Andersson, B.; Elam, M.; Bergmann Sverrirsdottir, Y.; Eisenhofer, G.; Waagstein, F., 1999:
Metoprolol treatment reduces sympathetic nerve activity in patients with heart failure

Hamelin, B.A.; Methot, J.; Pilote, S.; Poirier, P.; Dumesnil, J.; Turgeon, J., 1999:
Metoprolol/diphenhydramine interaction in men with high and low CYP2D6 activity

Agatha, S.; Foissner, W., 2000:
Metopus, Ciliophora incertae sedis Morphogenesis does not support a relationship with haptorid gymnostomes and heterotrich clevelandellids as indicated by gene sequence data

Victor, J.D.; Mechler, F.; Reich, D.S.; Aronov, D., 2003:
Metric - space analysis of multineuronal responses algorithmic improvements allow for extension to multiple neurons

Hall, R.L., 1999:
Metric analysis of non-metric traits categorizing nasal form

Hanihara, T.; Higa, T.; Ishida, H., 2003:
Metric and nonmetric dental variations of major human populations in the world

Bowden, S.C.; Reilly, R.E.; Bardenhagen, F.J.; Cook, M.J., 2003:
Metric invariance of the measurement model underlying symptoms of mood disturbance in patients with temporal lobe epilepsy

Aubin, M.M., 2003:
Metric sexing methods and commingled skeletal collections A better demographic profile?

Noest, A.J.; Van Den Berg, A., 2003:
Metric shape from stereo Prediction of disparity-curvature templates controlled by vergence

Schrein, C.M., 2004:
Metric variation in the dentition of Ouranopithecus macedoniensis

Santalla, F.; Casanova, J.C.; Feliu, C.; Laplana, N., 2000:
Metrical and genetical variability of Rodentolepis asymmetrica from arvicolid rodents

Santalla, F.; Casanova, J.C.; Feliu, C.; Laplana, N., 2000:
Metrical variability of Rodentolepis straminea from Apodemus spp in Spain

Dobiesz,N.E.; Hecky,R.E.; Johnson,T.B.; Sarvala,J.; Dettmers,J.M.; Lehtiniemi,M.; Rudstam,L.G.; Madenjian,C.P.; Witte,F., 2010:
Metrics of ecosystem status for large aquatic systems - a global comparison

Fuller, J.H., 1999:
Metrics of human gaze shifts and reference anchors

Edelman, J.A.; Cherkasova, M.V.; Nakayama, K., 2001:
Metrics of non-visually guided saccades are enhanced by prior post-saccadic feedback

Schneider, L.S.; Giacobini, E., 1999:
Metrifonate A cholinesterase inhibitor for Alzheimers disease therapy

Ormrod, D.; Spencer, C., 2000:
Metrifonate A review of its use in Alzheimers disease

Mega, M.S.; Cummings, J.L.; Dinov, I.D.; Masterman, D.M.; Felix, J.; O'connor, S.M.; Reback, E.R.; Toga, A.W. , 1999:
Metrifonate clinical benefits are correlated with activation of specific neuronal networks

Moon, A.; Smith, T., 2003:
Metrifonate effects on lipoprotein metabolism by inhibition of lipase and serum cholinesterase

Forchetti, C.; Cyrus, P., 1999:
Metrifonate improves cognitive performance in patients with Alzheimers disease despite concurrent mild ischemic damage

Bergman, H.; Chertkow, H.; Murtha, S.; Whitehead, V., 1999:
Metrifonate improves specific attentional measures in Alzheimers disease

Masterman, D.; Cummings, J.; Cyrus, P.; Gleeson, M., 1999:
Metrifonate improves the psychiatric and behavioral symptoms of Alzheimers disease in controlled clinical studies

Farlow, M.; Hake, A.; Moeller, J., 1999:
Metrifonate produces a clinical response in over 90% of treated Alzheimers patients

Puissant, S.; Voisin, J.F.ancois, 1999:
Metrioptera bicolor , new species for the department of the Pyrenees-Orientales , its macropterism, comparison with Metrioptera azami

Anonymous, 1999:
Metrogil-jelly in treatment some dermatoses

Galle, P.; Paulin, R.; Coursaget, J., 2003:
Metrological data and risk assessment in France during the Chernobyl accident Historical statement

Dybkaer, R., 1999:
Metrological traceability in clinical chemistry

Schneiders, G.E.; Brown, J.C.; Manalo, J., 2000:
Metrology, a tool and approach to ensure data quality

Harikrishnan, P.; Bindayna, K.M., 2002:
Metronidazole Avoid it unless its very much indicated

Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file: